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Abstract 
The aim of this study was to evaluate the behavioural effects of inhaled bergamot, 
geranium and a combination of these oils in three novelty evoked tests of anxiety. 
Sixty adult Hooded Rats (Rattus norvegicus), with 10 rats randomly assigned to 
one of the 6 test groups; three essential oil treated groups, and three control 
groups. The essential oil groups consisted of bergamot, geranium and a combined 
group, i.e. the combination of bergamot and geranium oil. The control groups 
consisted of the odour and vehicle control, with the anxiolytic drug diazepam as a 
positive control. The behaviour of rats was assessed on the elevate-plus maze, 
open-field and social interaction test. Diazepam increased open arm entries and 
the time spent in the open arms, decreased time spent in closed arms and 
increased the number of head-dips and unprotected stretch-attends in the EPM. In 
the open-field diazepam increased immobility time, decreased ambulation, 
increased grooming activity and reduced the amount of time spent exploring the 
arena. Similarly, diazepam decreased the frequency of separations, sniffs, follows, 
crawls, passive and active interactions with test partners in the social interaction 
test. Bergamot, geranium and the combination of the two oils increased total arm 
entries in the elevated-plus maze. Bergamot increased locomotion and exploratory 
behaviour in open-field and decreased contact latency and increased passive and 
active interaction between the rat pairs in the social interaction test. Geranium 
decrease immobility and increase the time spent rearing in the open-field and also 
increased active interaction, i.e. partner sniffing and decreased the amount of time 
the rat pairs spent apart in the social interaction test. The combination of bergamot 
and geranium oil increased locomotion and the time spent in Zone2, and also 
increased exploratory behaviour, i.e. the frequency and duration of rears in the 
open-field. In the social interaction test, contact latency was shortened and active 
and passive interactions between rat pairs were increased by the combination of 
essential oils. The present study established that bergamot, geranium, and the 
combination of the two oils had a stimulating effect in the elevated-plus maze and 
an anxiolytic effect in the open-field and social interaction tests when inhaled. 
Furthermore the study also demonstrated that the combining of the oils had a 
potentiating effect on the anxiolytic properties of the single oils. 
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Introduction 
 
1.1. Historical overview 
1.1.1. The development of contemporary medicine  
Throughout the ages people relied on the healing properties of plants to 
combat the rigors of illness, disease and physical injury. Archaeological discovery 
of prehistoric cave paintings confirms the use of plants in spiritual and healing 
rituals. Early man discovered by chance that some of the leaves, berries, and roots 
that he gathered for food made sick people feel better, and that their juices helped 
wounds to heal. Initially with only the intention of adding fuel, when the twigs of 
some bushes or trees were thrown on the fire, the smoke and aroma that they gave 
off made people drowsy, happy or excited. The “smoking” of patients was one of 
the earliest forms of medicinal rituals. The use of fumigation with aromatic plants 
remained a standard medical practice right up to the present century. Until 
relatively recently French hospitals burnt thyme and rosemary in the wards as a 
disinfectant (Eisenberg et al., 1998).  
The earliest documented medical texts date back to the Egyptians who 
were using aromatics as far back as 4500 BC for medical and cosmetic purposes, 
as well as for the embalming of their dead (Eisenberg et al., 1998). Embalmers 
utilised the natural antiseptic and antibiotic properties in plants, spices and resins 
to preserve the body after death (Ryman, n.d.).  The Ebers Papyrus lists over 800 
herbal remedies and prescriptions for various ailments, the plants used included 
aniseed, cedar, onion, garlic, cumin, coriander, castor oil, grape and watermelon. 
The ‘Classic Herbal’ text of Indian Ayurvedic medicine (3000 BC) and the 
‘Yellow Emperor’s Classic of Internal Medicine’ written by the Chinese emperor 
Huang Ti (2650 BC), provide further documented examples of the use aromatic  
oils, spices and herbs around the world (Eisenberg et al., 1998). 
Hippocrates (460-370 BC) known as the father of medicine, recommended 
the burning of aromatic oils to prevent the spread of plague. Due to the lack of 
coherent records, what was happening medically in Europe between the fall of the 
Roman Empire and the 10th century is sketchy. However, from the ‘Middle Ages’ 
and throughout the Tudor era, many forms of plant medicine were utilised by 
doctors, apothecaries and lay people alike. Little bouquets of aromatic herbs, 
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known as ‘tussy-mussies’, were carried in public places to ward off infection, 
especially the plague (Eisenberg et al., 1998). During the Renaissance (1400-
1700) explorers like Columbus initiated the development of contemporary 
medicine as we know it, with the discovery of distant cultures, medical texts and 
the importation of exotic plants and herbs (The Applied History Research Group, 
1997).  
By the 17th century the growing new science of experimental chemistry 
gave rise to new uses for plant extracts in medicine. The spate of witch-burning 
coincided with this rise in biomedical therapy as the medical establishment 
wished to suppress the knowledge of the village ‘wise-women’. Scientists 
continued to research the active ingredients of medicinal plants which remained 
the mainstay of medicine due to availability and cost effectiveness throughout the 
18th and 19th centuries (Eisenberg et al., 1998). Many plant extracts such as 
caffeine, quinine, morphine and atropine etc., were discovered (Zhang, 2004). 
With the advent of World War, and the greater demand for quicker more effective 
medicines, synthetic drugs derived from coal-tar by-products,  began to replace 
natural ingredients (Eisenberg et al., 1998).  
 
1.1.2. The rise in popularity of alternative therapies 
The flower-power age of the 1960s and 70s saw a return to more natural or 
alternative therapies. Interest in alternative therapies has continued to grow since 
the 1970s. According to a survey conducted by Harvard Medical School in 1997; 
between 1990 and 1997, the American population made around 627 million visits 
to alternative medical practitioners, spending an estimated $27 billion of their own 
money on alternative therapies and medicines. In contrast, Americans only made 
386 million visits to a general practitioner. That is a 47.3% growth in the 
utilization of alternative therapies since 1990 (Eisenberg et al., 1998). In Australia 
57% of the population now use some form of alternative medicine (Bensoussan, 
1999). In Europe 46% and 49% of the German and French population 
respectively, utilize alternative therapies, illustrating the global popularity of 
alternative medicine (Fisher & Ward, 1994). Between 1991 and 1997 the use of 
herbal medicine in the United States grew by 380% and the use of vitamin therapy 
by 130% (Eisenberg et al., 1998). 
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Similar trends are also reflected in New Zealand; in 1987, 37% of the 463 
outpatients with cancer surveyed, sought advice about complementary/alternative 
medicine (CAM) (Ernst & Cassileth, 1998). A 1990 survey examining the attitude 
of General Practitioners (GP’s) toward CAM revealed,  30% of Auckland GP’s 
practiced some form of CAM and 68.7% referred patients to CAM practitioners 
(Poynton, Dowell, Dew, & Egan, 2006). Of the 251 children surveyed in 1999, 
who were admitted to the Starship Childrens Hospital in Auckland with acute 
illness, 18% received complementary treatments while hospitalised (Armishaw & 
Grant, 1999). 
The resurgence of alternative therapies is partly due to its holistic 
approach which is focused on disease prevention, by treating the cause through 
strengthening the body’s own natural defences. In contrast conventional medicine 
is organ specific, relying primarily on surgical or pharmacological interventions, 
focused on symptom relief rather than prevention (Larsen, 2008). For example, 
most cancer chemotherapy regimes make use of highly cytotoxic drugs that target 
proliferating cells. However the non-discriminatory nature of these drugs leads to 
severe side effects in normal cells with a high proliferative index, i.e. the 
gastrointestinal tract and the bone marrow.  
Another reason for the shift towards alternative therapies would be a  
general disillusionment with conventional medicine due to the numerous side 
effects, their ineffectiveness to treat several chronic diseases, microbial resistance, 
and the high cost of new drugs (Humber, 2002). For example, antipsychotic drugs 
have been associated with a range of side effects which include Parkinsonism, 
requiring further drugs to manage the associated muscle tremors. There is still no 
definitive cure for cancer, and drugs like Herceptin offer little hope because at a 
cost of $100,000 US per year  (Fleck, 2006) this is unaffordable to the average 
breast cancer sufferer. The world is plagued by what is termed ‘superbugs’, 
virulent strains of the common cold, resistant to many antibiotics (Australian 
Broadcasting Corporation, 1999).  
Hospitals are now the third largest killer in Australia and over one million 
people are seriously injured in American hospitals every year. Blood infections 
acquired in American hospitals cause 62,000 fatalities every year and bypass 
surgery results in 25,000 strokes a year. Two million patients experience adverse 
drug reactions in hospitals in the United States every year; of these, over 100,000 
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die making hospital-induced adverse drug reactions the fourth leading cause of 
death after heart disease, cancer, and stroke (Anderson, 1995; Bates et al., 1995; 
Cordner, 1995; Lazarou, Pomeranz, & Corey, 1998; Pittet & Wenzel, 1995; 
Roach, Kanchuger, Mangano, & Newman, 1996).  
Although conventional pharmaceuticals work more rapidly than natural 
therapies, the homeostatic properties of essential oils (Fujiwara, Komori, & 
Mitsuo Yokoyama, 2002) may provide a viable alternative to conventional 
pharmaceuticals, without negative side effects and the treat of addiction. Essential 
oils, specifically monoterpenes, have chemo-preventative properties, i.e. they 
dilute the harmful consequences of cytotoxic drugs (Morita et al., 2003), they are 
also effective cancer suppressors in their own right (De Angelis, 2001). The 
antioxidating properties of essential oils have been found to be effective against 
heart disease (Graßmann, Hippeli, Spitzenberger, & Elstner, 2005). Oils rich in 
phenolic constituents such as eugenol and thymol (Naderi, Asgary, Ani, Sarraf-
Zadegan, & Safari, 2004), have been effective against atherosclerosis, and 
lavender has been indicated as having antiplateletic and antithrombotic properties, 
i.e. decrease platelet aggregation and stop blood from clotting (Ballabeni et al., 
2004). Rosemary has demonstrated antidiabetic properties, displaying 
hyperglycaemic and insulin release inhibitory effects in diabetic rabbits (Al-
Hader, Hasan, & Aqel, 1994).  
 
1.2. Stress, anxiety and depression 
Stress is a leading precursor to diseases like anxiety and depression 
(Cohen, Kessler, & Underwood Gordon, 1995; Wilkinson & Marmot, 2003). 
Cohen, Kessler, & Underwood Gordon (1995), define stress as an, “environmental 
demand that exceeds the adaptive capacity of an organism, resulting in 
psychological and biological changes that may place a person at risk of disease”. 
Conditions associated with long term stress also include diabetes, high blood 
pressure, cardiac arrest, stroke anorexia, obsessive compulsive disorder, alcohol 
and drug abuse, and hyperthyroidism (National Institute of Child Health and 
Human Development, 2004). 
When we experience stress the thalamus, believed to act as a translator or 
processor of the information received from the brain, activates the hypothalamus. 
The hypothalamus in turn activates; the endocrine system, responsible for the 
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release of extracellular signalling molecules/hormones; and the autonomic 
nervous system, which influences heart rate, digestion, respiration rate, etc. 
(Jerajani, 2006). Effectively, the stress hormones released by the endocrine 
system bath the immune cells in molecules which tell them to stop fighting (Wein, 
2000). The dysregulation of the neuroendocrine and immune function is thought 
to be associated with some psychosomatic and psychological disorders, i.e. 
chronic stress makes the body vulnerable to, anxiety, depression, infection, colds 
and flu (Komori, Fujiwara, Tanida, Nomura, & Yokoyama, 1995). 
Anxiety and depression can have cognitive, affective, physiological, and 
behavioural implications. Examining the effects of anxiety; at a cognitive level, 
stimuli or situations can be construed as threatening; affectively a person may feel 
apprehensive, tense or uneasy; and physiologically, autonomic arousal prepares 
the body for flight or fight and in extreme case freezing or immobility. 
Correspondingly, examining the effects of depression; cognitively, negative 
events are internalised; affectively a person will have a low mood, feel guilty, 
worthless or suicidal; and physiologically a person may experience weight 
gain/loss, insomnia/hypersomnia and psychomotor agitation or retardation (Carr, 
2006).  
In Australia, stress related disorders like anxiety/depression are the biggest 
non- fatal drain on the national disability budget (Mathers, Vos, & Stevenson, 
1999). Paradoxically, despite the over-whelming growth in popularity of 
complementary/alternative therapies, compared to contemporary medicine there is 
insufficient empirical evidence to support their efficacy as a treatment for stress 
and depression. This is disturbing if one considers that only 50 %  of Australians 
who suffer from depression seek evidence-based professional help, relying instead 
on alternative interventions (Andrews & Sanderson, 2000). More surprisingly, in 
a national survey only 29% of the Australian population regard anti-depressants as 
likely to be helpful. On the other hand, 57% of the population regarded vitamins, 
minerals, tonics or herbal medicines as likely to be helpful (Andrews & 
Sanderson, 2000).  In New Zealand, of the 1043 patients surveyed who accessed 
the Emergency Room (ER) at Waikato Hospital, between December 2004 and 
January 2005, 38.1% utilized some form of CAM. Of the 397 CAM users 7% 
used St John Wort as a treatment for depression (Nicholson, 2006). 
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Alarmingly, there is no evidence to support the effectiveness of ginkgo 
biloba, natural progesterone, selenium or glutamine; all qualitatively popular self-
help interventions for depression.  Of the vitamins examined, only folate (vitamin 
B9) showed any promise as an antidepressant (Jorm, Christensen, Griffiths, & 
Rodgers, 2002). Conversely, research demonstrates that essential oils offer a 
potential natural alternative to conventional medicine for several psychiatric 
(Zhang, 2004) and physiological disorders (Edris, 2007), which further reiterates 
the need for more empirical research into the possible therapeutic benefits of 
essential oils.   
Needless to say not everyone who experiences a traumatic event or other 
stressors will develop anxiety and/or depression. Vulnerability to the negative 
effects of stress would depend on environmental and predisposing factors 
(Barlow, 2000).  Environmental and predisposing factors would include; illness or 
injury, abuse, loss, violence, low socio-economic status and genetic vulnerability, 
inhibited temperament, low self-esteem and an external locus of control (Carr, 
2006). 
 
1.2.1. Comorbidity of anxiety and depression  
Current diagnostic manuals allow for the diagnoses of major depressive 
disorder and one or more anxiety disorders on Axis I; and for the classification of 
mixed anxiety disorder NOS, defined as a mixture of anxiety and depressive 
symptoms (American Psychiatric Association, 2000). Earlier versions of the 
Diagnostic and Statistical Manual of Mental Disorders (DSM-III) however, 
identified anxiety and depression as two distinctly separate disorders (Levine, 
Cole, Chengappa, & Gershon, 2001). This distinction has resulted in research 
focused on anxiety and depression separately, until recently it was believed the 
drugs used to treat depression could not be used to treat anxiety and visa versa 
(Levine, Cole, Chengappa, & Gershon, 2001). However, the high rate of co-
morbidity, and emerging evidence, indicating a shared serotonergenic and 
noradrenergenic dysfunction,  suggesting anxiety and depression may share 
common neurobiological pathways (Argyropoulos, Sandford, & Nutt, 2000; Jack, 
1996), has resulted in revisions to their diagnostic criteria.  
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1.3. Psychopharmacology 
Second-generation antidepressants, such as selective serotonin re-uptake 
inhibitors (SSRI), e.g. paroxetine, fluvoxamine, fluoxetine, and sertraline, have 
superseded psychotropic drugs, like monoamine oxidase inhibitors (MAOI) and 
tricyclic antidepressants (TCA) in popularity, due to the side effects associated 
with them. Antidepressants work by inhibiting the re-uptake of the 
neurotransmitters norepinephrine and serotonin by the neurons. In the central 
nervous system, serotonin plays an important role as a neurotransmitter in the 
modulation of anger, aggression, body temperature, mood, sleep, sexuality, 
appetite, and metabolism, as well as stimulating vomiting (Jack, 1996). 
Despite increasing focus on the use of antidepressants and other agents for 
the treatment of anxiety related disorders, benzodiazepines have remained a 
mainstay of anxiolytic pharmacotherapy due to their speed and robust efficiency 
(Argyropoulos, Sandford, & Nutt, 2000; Schatzberg, Cole, & DeBattista, 2007; 
Stevens & Pollack, 2005; Uhlenhuth, Balter, Ban, & Yang, 1999a). 
Benzodiazepines have a continuum effect, between its depressant and stimulant 
properties, on the central nervous system via the modulation of the GABAA 
receptor, the most prevalent inhibitory receptor within the brain. As such the 
sedating properties of benzodiazepines are useful for the short-term treatment of 
severe anxiety (Bulach, Myles, & Russnak, 2005; McKernan et al., 2000). 
Benzodiazepines are usually administered orally for the treatment of anxiety and 
at low doses for depression (Petty, Trivedi, Fulton, & John Rush, 1995).  
Occasionally lorazepam or diazepam may be given intravenously for acute 
anxiety (Uhlenhuth, Balter, Ban, & Yang, 1999b). Contra-indicators of 
benzodiazepines include, drug interactions, psychomotor retardation, memory 
impairment, disinhibition (indiscretionary or antisocial behaviours normally 
suppressed by social restraints), depression/emotional blunting, and addiction 
(Longo & Johnson, 2000). 
 
1.4. Essential oils 
Alterations in brain chemistry due to anxiety/depression provide a popular 
rational for a psychopharmacology treatment approach. However, as Homes 
(1998) points out, social, environmental, psychological influences as well as 
nutrition may also be important mediating factors for anxiety/depression. 
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Considering the function of the amygdala and the fact that the olfactory system 
provides a more direct route to the hypothalamus than either, the intravenous or 
intrathecal route (an injection into the vein or spinal canal, respectively), there is a 
strong justification for research examining the psychological benefits of essential 
oils through inhalation (Clark, 1983). 
From an evolutionary perspective, the sense of smell was vital to the 
survival of primitive men, for detecting danger and familiarizing with an 
unfamiliar world (Barnham & Broughan, 2002). This innate survival instinct is 
still evident today, when a baby is born because his eyesight is poor, he uses his 
sense of smell to recognise his mother and seek nourishment by detecting the 
pheromones a mother secretes from her breast, as well as the sweet odour of her 
milk (Ryman, n.d.; Worwood, 1995).  
Anatomically, research demonstrates that axons (nerve fibres) of the 
sensory neurons in the nose, project from the vomeronasal organ to the olfactory 
bulb, and from there to the hypothalamus via the amygdala (Scott & Chafin, 1975; 
Zald & Pardo, 1997). The primary role of the amygdala is the formation and 
storage of memories associated with emotional events (Amunts et al., 2005).  
Based on human evolution and the structure of the olfactory system, it is 
believed that  physiological and psychological imbalances, produced through 
chronic stress, can be normalized through the inhalation of essential oils without 
the side effects associated with conventional psychotropic drugs (Fujiwara, 
Komori, & Mitsuo Yokoyama, 2002; Komori, Fujiwara, Tanida, Nomura, & 
Yokoyama, 1995).  
Essential oils offer a reasonable alternative to the psychopharmacological 
approach for the treatment of anxiety/depression because they have both a direct 
physiological influence, due to their chemical properties and permeability 
(molecular size), and an indirect psychological influence, due to their hedonic 
properties (see section 1.4.3) (Broughan, 1998; Holmes, 1998).  
Aromatherapy has become synonymously associated with essential oils. 
The term aromatherapy was first coined in 1928 by Gattefossé, a French chemist 
working in his family’s perfumery business, after discovering by accident that 
lavender was able to rapidly heal a severe burn on his hand and help prevent 
scarring (Gattefossé, 1993). Most flowers, seeds, barks, grains, roots and resins as 
well as leaves contain essential oils.  
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Essential oils can be obtained from plants in a number of ways (Ryman, n.d.). 
 Maceration - flowers or petals are spread on a tray lined with fat or vegetable 
oil, the essential oil is then separated from the fat with solvent and purified.  
 Distillation - Steam is passed over leaves or flowers, possibly in a vacuum or 
under pressure, so the essential oil within them vaporise. When the steam is 
cooled the essential oils condense and because they are not water soluble, they 
separate and can be easily collected. 
 Dissolving - volatile solvent like alcohol used to extract essential oils from 
gums and resins.  
 Pressing - commonly used to squeeze oils from rinds and peels for fruit. 
 
1.4.1. Chemical constituents  
 The properties of essential oils are based on their chemical profile. There 
are two groups of chemical constituents of significant therapeutic value (Table 1); 
hydrocarbons, which are made up of terpenes; and oxygenated compounds, which 
include esters, aldehydes, ketones, alcohols, oxides and phenols (Dunning, 2006; 
Ryman, n.d.; Sellar, 1992). The acids, lactones, sulphur, and nitrogen compounds 
are the constituents that fall outside of these two main groups.  
Quantitative differences between the neurotropic effects of lavender oil 
and its constituents on the central nervous system, suggest the sedating activity of 
the oil is not mediated solely by any specific constituents, but rather by the 
combination of the constituents on the whole (Atanassova-Shopova & Roussinov, 
1970). Atanassova-Shopova and Roussinov, (1970) suggest the difference 
between the ‘whole’ oil and its individual constituents may be the potentiating 
effect of the combined constituents, by reducing the toxicity of the terpenes and 
alcohols. Gattefosse also found that essential oils were more effective in their 
totality than either their synthetic substitutes or any of their isolated ingredients 
(Gattefossé, 1993).  
The homogeneous nature of essential oils could account/provide another 
rational for research regarding their viability as a treatment for anxiety and 
depression.  
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Table 1 
The major chemical constituents of essential oils, their reported properties and examples 
of essential oils that contain the particular chemical in their composition. 
Major chemical 
constituents 
Example essential oils Reported therapeutic 
properties  
Terpenes 
Monoterpenes 
Almost all essential oils 
contain terpenes. They are 
particularly prevalent in 
citrus oils except Bergamot. 
 
Sesquiterpenes 
 
 
 
 
Diterpenes 
Not common due to their 
molecular weight. 
Tritepenes & tetraterpenes 
More common in herbs as 
sterols, steroids and saponins 
carotenoids. 
 
Alcohols 
Considered the most 
therapeutically beneficial 
Monoterpenols 
 
 
 
 
 
 
Sequiterpenols 
 
Phenols 
 
 
 
Aldehydes 
Sedating when inhaled 
 
 
 
Ketones 
 
 
 
Esters  
 
 
 
 
 
Oxides 
 
 
Lemon, Orange, Juniper, Neroli, 
Pine, Rosemary, Melissa, Rose, 
Eucalyptus, Frankincense,  Tea-
Tree, Lavender, Geranium 
(Sabinene)* 
 
Black Pepper, Tea-tree, 
Cedarwood, Camomile, Basil,  
Clary Sage, Ylang-ylang, 
Ginger,  Melissa, Rosemary,  
Lavender 
 
 
 
 
 
 
 
 
 
 
 
Camphor, Rosemary,  
Marjoram, Sandalwood,  
Lavender, Geranium (Geraniol, 
Citronellol, Linalool, Myrtenol, 
Terpineol)* 
Bergamot ( Linanool, Nerol, 
Terpineol)*  
 
 
Jasmine, Patchouli, Vetiver, 
Camomile, Geranium 
(Eugenol)* 
 
Oregano, Thyme, Aniseed, 
Fennel, Nutmeg, Vanilla, 
Tarragon, Clove, Geranium 
(Citral)* 
 
Lemon verbena, Melissa, 
Citronella, Cinnamon, 
Geranium (Methone)* 
 
Aniseed, caraway, Dill, Hyssop, 
Sage, Bergamot (Linalyl 
acetate)* 
 
 
 
Citronella, Lavender, Lemon, 
Melissa, Rose, Bergamot* 
 
Analgesic 
Anti-bacterial 
Anti-septic 
Anti-viral  
Bactericidal 
Stimulant** 
 
 
 
 
 
 
 
 
 
 
 
 
 
Anti-fungal 
Hepatic 
Vaso-decongestant 
Sedative** 
 
 
 
 
 
 
 
 
Very stimulating to the immune 
system 
Sedative in large doses 
 
Anti-pyretic 
Anti-inflammatory 
Vaso-dilator 
Sedative**  
 
Analgesic 
Mucolytic 
Sedative 
 
Calming 
Anti-spasmodic 
Sedative** 
Regulates sympathetic nervous 
system 
 
Expectorant 
* Indicates essential oils of interest to this study. 
** Indicates properties of interest to this study
1.4.2 Oil combining 
In aromatherapy, rarely are single oils utilized, but rather a combination or 
blend of oils are mixed with a carrier oil, usually grape seed, olive or peanut oil. 
Considering the potentiating effect the combined constituents in essential oils 
have (Gattefossé, 1993), it stands to reason the combination of different essential 
oils could provide a similar potentiating effect.  
In a study by Lemon (2004), patients suffering from depression were 
massaged fortnightly over a 12 week period. Four drops, from a range of 9 
essential oils, chosen because of their therapeutic properties for relieving anxiety 
and depression, were selected according to the presenting physical and 
psychological symptoms at the time of treatment, e.g. anxiety, depression, 
headaches and sleep problems. Bergamot, clary sage and lemon oil were selected 
for their uplifting, euphoric properties, and lavender because of it versatility. 
Roman chamomile and geranium were selected for their soothing, calming 
properties, and rose, sandalwood and jasmine oil for their sedating properties. 
Patients demonstrated significant improvements on the Montgomery-Åsberg 
Depression Rating Scale (MADRS), the Tyler Brief Anxiety Scale (TBAS) and the 
Hospital Anxiety and Depression Scale (HADS).  
In another study Komori et al., (2006) demonstrates the combined effect of 
sandalwood, juniper berry, rose and orris, prolonged pentobarbital induced sleep 
time in rats by 15 %, a 10 % compared to the individual oils. Caution should be 
taken however, to ensure the oils combinations are homologous in their affect and 
not counteractive to each other, i.e. either simulating or sedating but not both 
(Hongratanaworakit, 2004).  
 Following this chain of thought, most essential oils studies have focused 
on the effects of individual oils and/or its component parts, however few have 
considered the combined effects of two or more essential oils. 
 
1.4.3. Human research  
In humans, essential oils are absorbed into the body via the nose/mouth or 
the skin (Worwood, 1995). Scientific analysis of, perspiration, faeces, urine, 
breath (Worwood, 1995), blood and tissue samples, have revealed that inhaled 
essential oil components have been detected  in the skin, lungs,  olfactory bulb 
and the brain (Buchbauer, Jirovetz, Jager, Plank, & Dietrich, 1993; Inouye, 2003). 
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Electroencephalography (EEG), measuring the electrical activity of the brain 
(Diego et al., 1998; Lorig, Herman, Schwartz, & Cain, 1990); magnetic resonance 
imaging (MRI), which highlight activated parts of the body and brain (Poellinger 
et al., 2001); heart rate and blood pressure (Hongratanaworakit, 2004);  
electrodermal activity, the resistibility of the skin to a mild electric shock 
(Jellinek, 1998); and psychometric tests have been utilized to demonstrate that 
odours can influence cognition and mood (Moss, Cook, Wesnes, & Duckett, 
2003).  
In general it appears that; floral, spicy and minty odours are simulating, 
producing increases in contingent negative variation (CNV is a measure of 
activity in the motor cortex the brain leading up to voluntary muscle movement); 
while citrus, herbal and woody odours are sedating, producing decreases in CNV. 
However, neroli (produced from the blossom of the bitter orange tree) which 
contains both floral (geraniol) and citrus (linalool) components, can either be 
stimulating or sedating depending on whether it is perceived as either citrus or 
floral (Torii, 1997). Similarly, essential oils may also be either stimulating or 
sedating depending on necessity (Sakamoto, Minoura, Usui, Ishizuka, & Kanba, 
2005), e.g. lavender oil may be either stimulating or sedating due to the 
monoterpenes and alcohols in its chemical composition. To elaborate, Yerkes-
Dodson law contends that when task demand or arousal exceeds a maximum 
threshold additional stimulation would impair performance, however Degel & 
Koster (1999) reported that lavender, which was expected to impair performance 
due to it stimulating properties, improved performance which suggests it sedating 
rather than its stimulating properties must have been utilized.  
In a study by Diego et al. (1998); lavender produced an increase in beta 
power, suggesting increased drowsiness; and rosemary showed decreases in 
frontal alpha and beta power, suggesting increased alertness. Cognitively, the 
stimulating properties of cinnamon improved  memory performance  (Zoladz & 
Raudenbush, 2005), while lavender and rosemary, enhanced the speed and 
accuracy of math computation (Diego et al., 1998). Further more, patients 
exposed to lavender or orange aroma showed a mood improvement and a 
reduction in anxiety while waiting for dental treatment (Lehrner, Marwinski, 
Lehr, Johren, & Deecke, 2005). The sedating properties of lavender have also 
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proven beneficial to sleep disorders, promoting deep sleep (Goel, Kim, & Lao, 
2005; Komori et al., 2006).  
There is evidence to suggest the psychological effects of odours in human 
studies are mediated by their hedonic valence (Moss, Howarth, Wilkinson, & 
Wesnes, 2006). Hedonic valence is a conditioned response influenced by 
exposure, experience, culture, beliefs, expectation (Ayabe-Kanamura et al., 1998; 
Broughan, 2005; Kirk-Smith, van Toller, & Dodd, 1983) and gender (Fitzgerald et 
al., 2007). Barnham and Broughan, (2002) tested the influence of hedonics on 
emotion and task performance of children between the ages of 2 and 11, in 
pleasant and unpleasant odour conditions. The results reveal no significant age 
difference in performance in the unpleasant condition, suggesting an 
innate/evolutionary reaction to unpleasant odours. Older children responded more 
favourably than younger children in the pleasant odour condition however, 
indicating a more hedonic/learnt response to pleasant odours based on exposure 
and experience.  Odours are experienced within the context of environmental 
situations i.e., if an odour is experienced in a situation or environment that is 
emotionally charged or pleasant/relaxing, it may have either a stimulating or 
relaxing effect, respectively (Jellinek, 1998). Thus odours acquire hedonic values 
through pairing with emotionally significant events (Kirk-Smith, van Toller, & 
Dodd, 1983) which  can also result in a placebo effect (Jellinek, 1998; Knasko, 
Gilbert, & Sabini, 1990). 
Due to the hedonic influence of odours in humans, it may be argued that 
animal studies provide a more accurate prediction of the 
pharmacological/physiological effect of essential oils because one can safely 
assume that any changes in behaviour are unlikely to be cognitively mediated 
(Broughan, 1998).  
 
1.4.4. Animal research 
The sedatory and stimulating effects of essential oils, found in human 
studies, have been mirrored in animal studies.  Lavender and camomile,  rosemary 
and peppermint,  demonstrated sedating and stimulating effects on dogs housed in 
rescue shelters, respectively (Graham, Wells, & Hepper, 2005). When exposed to 
the ambient odour of lavender, dogs with a history of travel-induced excitement 
spent significantly more time resting and sitting, and less time moving and 
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vocalizing (Wells, 2006).  Umezu, (1999) demonstrated that rose oil exhibits 
similar anti-conflict properties to diazepam with mice, in the Vogal/Geller conflict 
test. In another study, lemon odour demonstrated antidepressant properties by 
significantly reducing the total immobility time of rats in a forced-swim test and 
significantly decreasing the total locomotor activity in an open-field test (Komori, 
Fujiwara, Tanida, Nomura, & Yokoyama, 1995). 
In her study of animals and their responses to essential oils, Ingraham 
(2004) observed that animals have an innate ability to choose the plants or aromas 
that would best respond or provide for their needs. Interestingly, herbivores and 
carnivores indicate a distinct preferential difference to essential oils. Ingraham 
observed that oils were ingested for internal ailments and inhaled for emotional 
problems. Animals showed a particular dislike for essential oils that contained 
cineole, e.g. rosemary, eucalyptus or tea-tree (manuka), except where these plants 
were part of their natural habitat. Animals also tended to avoid oils with 
monoterpenes with the exception of bergamot. These observations would suggest 
that careful consideration should be given in the utilization of essential oils in 
animal studies (Ingraham, 2004).  
In addition to the oils used in animal studies, careful consideration should 
also be given to subject selection because this can have a significant influence on 
test results. It has been proposed that different strains or breeds of rats could 
exhibit different levels of anxiety (Ramos, Berton, Mormède, & Chaouloff, 1997; 
Shepard & Myers, 2008). Studies reveal significant differences in anxiety and fear 
related behaviour of juvenile, adolescent and adult rats in the elevated plus maze 
(Imhof, Coelho, Schmitt, Morato, & Carobrez, 1993) and social interaction test 
(Garau, Marti, Sala, & Balada, 2000). Korte and de Boer (2003) report gender 
differences with regards to stress levels and stress response i.e. the amount of time 
spent in the open arm of elevated plus maze.  
 
1.5. Animal models of anxiety and depression 
Kalueff and Tuohimaa, (2004) describe the criterion of animal models in 
terms of face, predictive and construct validity. Face validity as they describe it, 
reflects “phenomenological similarities” between animal models and human 
pathology. However, as Smith (1965) points out, even when animal models 
demonstrate face, predictive and/or construct validity, behaviours observed in 
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animals, may have different meaning to similar human behaviours because 
humans are verbal. According to Kalueff and Tuohimaa, (2004) predictive 
validity is based on the ability to postulate a drug’s effectiveness on humans, 
based on its effects in animal models. Finally, the similarity of the theoretical 
rationale behind the pathology in humans and animals determines construct 
validity.  
Mc Kinney and Bunney (as cited in (Overall, 2000), outline five basic 
criterion for animal models to mirror human symptomology of stress related 
disorders. 
 The symptoms of the condition in animals should be reasonably analogous to 
those seen in humans. 
 There should be behavioural changes in both model and patient that can be 
objectively evaluated. 
 Independent observers should agree on the objective criteria for drawing 
conclusions about the subjective state. 
 The treatment modalities effective in reversing the human condition should 
have the same effect on the animal condition. 
 The model should be reproducible by other investigators. 
 
Animal models of anxiety and depression may be measured, i.e. based on 
changes in animal pathology, or induced through drugs, gene mutation, brain 
lesion/stimulation or stress (Kalueff & Tuohimaa, 2004). To elaborate, anxiogenic 
and anxiolytic drugs may be utilized to manipulate behavioural responses to 
different test conditions (Pellow & File, 1986; Rodgers & Dalvi, 1997; Wilson, 
Burghardt, Ford, Wilkinson, & Primeaux, 2004). Stress induced models include 
among others, Porsolt’s forced-swim test (Frazer & Morilak, 2005; Porsolt, 
Anton, Blavet, & Jalfre, 1978), foot-shocking (Pijlman & van Ree, 2002) and 
novel environments (Montgomery, 1955; Montgomery & Monkman, 1955), to 
name but a few.  
Novelty evoked stress models, based on the exploratory, social, defensive, 
and conditioned behaviours of animals (Wall & Messier, 2001), produce two 
affective dimensions, the activated component (agitation, anxiety) or the 
inhibitory/withdrawal component (sleep, appetite, and motor activity), i.e. 
depression (Frazer & Morilak, 2005). These behaviours can be manipulated 
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through early weaning, single/group housing conditions (Ferdman, Murmu, Bock, 
Braun, & Leshem, 2007; Newport, Stowe, & Nemeroff, 2002), selective breeding 
i.e., breeding of high or low anxiety related behaviours (Henniger et al., 2000; 
Langraf & Wigger, 2002; Landgraf & Wigger, 2003), exposure to predatory 
odours (Korte, DeBoer & Bohus, 1999; Korte & De Boer, 2003) or restraint 
(Albonetti & Farabollini, 1992; Korte, De Boer & Bohus, 2003). Korte, De Boer 
and Bohus (1999) maintain the presence of predatory odours and restraint 
conditions activates the defensive behaviours of animals and has a potentiating 
effect on test results.  
For ethical reasons and ease of use, only drug induced and novelty evoked 
models of anxiety and depression were considered in this study. These models 
include, the elevated plus-maze (Pellow, Chopin, File, & Briley, 1985), the open-
field (Hall, 1934) and the social interaction test (File & Hyde, 1978). Overall, 
(2000) suggests that novelty evoked animal models of anxiety and depression are 
more homologous to human symptomology because they tap into the instinctive 
behavioural instincts associated with survival, i.e. they measure the natural 
behaviours or responses of animals to novel environments or stimuli. 
 
1.5.1. Novel environments and animal behaviour 
In ‘prey’ animals, survival is an innate evolutionary instinct which covers 
the need to feed, propagate and avoid danger. In a novel environment this survival 
instinct produces a dichotomy between approach and avoidance (Montgomery, 
1955; Montgomery & Monkman, 1955), i.e. a conflict  between defensive 
behaviours (flight, fight or freeze) (Blanchard, Yudko, Rodgers, & Blanchard, 
1993); and risk assessment (the need to explore or assess potential danger, food 
sources etc.).  
From a research perspective the dichotomy between fear and risk 
assessment (approach/avoidance) behaviours, allows researchers to investigate the 
effectiveness of anxiolytic and anxiogenic drugs, i.e. drugs that reduce or increase 
levels of anxiety respectively (Arakawa, 2007). Behaviour analysis of rats 
selectively bred for high (HAB) and low (LAB) anxiety related behaviours, 
provides an accurate illustration of the defensive behaviours to expect from rats 
exposed to novel environments (Table 2) (Landgraf & Wigger, 2002; Salome et 
al., 2002).  
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Table 2  
Principal behavioural profiles in experimental models of anxiety and depression 
(taken from Kalueff & Tuohimaa, 2004). 
Behavioural Indices Anxiety Depression 
 
General locomotion 
Exploration 
Self-grooming 
Immobility 
Defecation/Urination 
Aggression 
Self-aggression 
Transitions between behaviours 
Risk assessment 
 
 
+ 
– 
                    + (frequency) 
                 + (freezing) 
+ 
+ 
0 
+ 
     + or – ** 
 
– 
– 
                 + (duration) 
                 + (despair)* 
? 
+ 
+ 
– 
– 
(+) increased; (-) decreased; (?) unclear or inconsistent effects; (0) no effects; *in Porsolt’s swim 
and tail suspension tests; **depending on the model 
 
 
1.5.2. The elevated plus-maze model 
The elevated-plus maze (EPM) model consists of a plus shaped maze with 
two open and two closed arms elevated above the floor (Figure 1). The design of 
the maze exploits the natural fear of rodents to avoid bright open elevated places 
and initiates a conflict between their defensive and risk assessment behaviours 
(Henniger et al., 2000).  
 
    
 
Figure 1. Rat in open-arm of Elevated-plus Maze 
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Open arm exploration is affected by the levels of anxiety, thus one would 
expect anxiolytic and anxiogenic drugs to increase or decrease open arm 
exploration, respectively (Pellow, Chopin, File, & Briley, 1985; Pellow & File, 
1986). Other risk assessment behaviours also include; head dipping, i.e. leaning 
over the edge of the open arms; and 'stretch attend postures', in which the rodent 
stretches forward on front paws then retracts back without moving the hind paws 
(Rodgers & Dalvi, 1997). Risk assessment behaviours may take place from the 
safety of the centre or closed arms of the maze (protected) or occur on the exposed 
open arm of the maze (unprotected) (Dawson & Tricklebank, 1995). Increased 
duration and frequency of these behaviours in the open unprotected arms of the 
EPM is indicative of lower levels of anxiety (Kalueff & Tuohimaa, 2004). 
Past studies have reported the anxiolytic effects of diazepam in the EPM 
are characterised by an increase in the number of entries and time spent in the 
open arms (Drapier et al., 2007) as well as a reduction in total entries (Pellow & 
File, 1986) in the maze. Diazepam also has an anxiolytic effect on risk assessment 
behaviours, by decreasing protected and increasing unprotected risk assessment 
behaviours (Dawson & Tricklebank, 1995). In the EPM, selective serotonin 
reuptake inhibitors (SSRIs), e.g. fluoxetine, cause a decrease in the number of 
entries and time spent in the open arms, however the number of total entries 
remains unaffected (Brocco, Dekeyne, Veiga, Girardon, & Millan, 2002; Drapier 
et al., 2007). Similarly, amphetamines cause a decreased ratio of entries and time 
spent in the open arms, with out a reduction in total entries in the EPM (Kask, 
Schiöth, Mutulis, Wikberg, & Rägo, 2000). 
The EPM has been utilized to examine the anxiolytic properties of 
essential oils. Mice injected intra-peritoneally with lemon verbena (Vale, Matos, 
de Lima, & Viana, 1999) and woundwort (Rabbani, Sajjadi, & Zarei, 2003), 
displayed a significant increase in the number of open arm entries and time spent 
on the open arms of an EPM. Similarly, mice treated with an oral dose of bitter 
orange showed significant increases in open arm entries and duration of 
exploration in the EMP (Carvalho-Freitas & Costa, 2002). Further more, exposure 
to lavender odour  (Bradley, Starkey, Brown, & Lea, 2007; Bridges & Starkey, 
2004)  and rose (Bradley, Starkey, Brown, & Lea, 2007) had an anxiolytic effect 
on gerbils in EPM.  
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1.5.3. The open-field model 
The open-field (OF) may be a circular, square or rectangular enclosure; 
however in this study a square arena was utilized (Figure 2). Changes to the size 
of the open-field affects moderate but not significant behavioural changes, as 
such, Eilam (2003) suggests that behaviours elicited in a small open-field are 
representative of general patterns of behaviour to novel environments.  
 
            
 
Figure 2. Single rat in Zone1 of open-field 
 
 
Like the EPM, the OF also exploits the dichotomy between the natural 
tendency of rodents to avoid bright open spaces and their need to explore novel 
environments. When exposed to an open-field rodents establish a home base in 
one of the corners from which they explore their environment, preferring to move 
along the walls of the OF (Haimovici, Wang, Cohen, & Mintz, 2001). Exploratory 
behaviours in the OF include, sniffing, and rearing, i.e. the rodent lifts forepaws 
off the ground and stretches vertically on hind legs (Prut & Belzung, 2003). 
Levels of anxiety and depression can be determined by measuring changes in 
ambulation and exploration activity (Komori, Fujiwara, Tanida, & Nomura, 1995; 
Vécsei & Widerlöv, 1990). Increased ambulation and exploration, as well as an 
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increase exploration of central more exposed parts of the OF are indicative of an 
anxiolytic effect (Prut & Belzung, 2003). 
Other useful measures of anxiety and depression in the OF include, 
immobility (freezing) and grooming behaviour (Kalueff & Tuohimaa, 2004). 
Increased immobility in the OF is characteristic of increased levels of anxiety and 
depression (Fromm, Heath, Vink, & Nimmo, 2004; Homberg et al., 2002). In 
rodents grooming plays an important role in behavioural adaption to stress, stress-
coping and de-arousal (Spruijt, Van Hooff, & Gispen, 1992). Grooming is 
sensitive to various stressors, psychotropic drugs and genetic manipulations. 
Anxiolytics like diazepam have demonstrated a reduction in rat grooming 
behaviour (Moody, Merali, & Crawley, 1988). 
The anxiolytic effect of diazepam in the OF causes an increase in 
locomotor and exploratory (rears and sniffs) behaviours as well as in increased 
exploration of the more exposed central parts of the arena; the ratio of grooming is 
reduced as well as the time spent immobile. Similarly, SSRIs have also 
demonstrated an anxiolytic effect by increasing the ambulation and exploration 
behaviours in the OF (Prut & Belzung, 2003). 
Examining the anxiolytic properties of essential oils in the OF, lemon 
verbena (Vale, Matos, de Lima, & Viana, 1999) and ginger (Felipe et al., 2008) 
have demonstrated a significantly reduction in the number of rears and grooming 
incidence in mice. Similarly, thistle demonstrated an anxiolytic effect in mice by 
increasing total locomotion and ambulation into the centre of the OF (Ambavade, 
Mhetre, Tate, & Bodhankar, 2006).  
 
1.5.4. The social interaction model 
Social interaction (SI) between two rodents is observed in the OF 
apparatus described in section 1.5.3. Once again the fear/risk assessment 
dichotomy is vital to the success of this model of animal anxiety and depression, 
with rats showing less socialisation under more aversive conditions, e.g. bright 
open spaces (File & Hyde, 1978).  
As outlined by Sala-Roca, Marti-Carbonell, Garau, Darbra and Balada, 
(2002), there are four groups of dependant measures in the social interaction 
model. The four groups consist of, active social behaviour (proximity and 
following, sniffing, social grooming, crawling over and under, escaping and 
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avoidance, passive social behaviour (passive interactions), activity/mobility 
(ambulation and exploration), and stress related behaviours (freezing and self-
grooming). File and Hyde (1978) suggest the more time a pair of test subjects 
spend in active social interaction the less anxious they are.  
Research suggest that diazepam has an anxiolytic effect on social 
interaction by increasing active and passive interaction (Cheeta et al., 2001). 
Amphetamines and SSRI antidepressants demonstrate anxiogenic effects by 
reducing social interaction, however chronic administration of SSRIs produces an 
anxiolytic effect on social behaviour (File & Seth, 2003).  
The odour of orange essential oil increased the social interaction between 
rats, demonstrating a decrease in anxiety compared to the control subjects (Leite 
et al., 2008). 
 
1.6 Aims 
Taken together, research suggests that the anxiolytic/antidepressant effects 
of essential oils can be detected when studying novelty evoked exploration in 
rodents. To date, animal research has focused on the most commonly used 
essential oils, such as lemon, rose and lavender, whilst others have been less well 
studied. However, there are other oils such as bergamot and geranium, which are 
reported to improve anxiety and depression in humans (Lemon 2004), which have 
not yet been tested in animals. Furthermore, both of these oils contain linalool and 
linalyl acetate (Sellar, 1992), two of the major constituents of lavender, which 
have sedative effects in mice (Buchbauer, Jirovetz, Jager, Dietrich, & Plank, 
1991).  
Therefore, the overall aim of this study was to evaluate the behavioural 
effects of inhaled bergamot, geranium and a combination of these oils in three 
novelty evoked tests of anxiety; the elevate-plus maze, open-field and social 
interaction test. A second aim was to compare the effects of these oils with the 
known anxiolytic diazepam. 
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Method 
 
2.1 Animals and housing 
Sixty Hooded Rats (Rattus norvegicus), bred at the University of Waikato 
were used in this study. They were adult males over 120 days of age with an 
average weight of 492.9g at the time of testing.  
The rats were housed in pairs in standard rodent cages sized (38x25x20 
cm). The cages consisted of a plastic tray like bottom covered in dry non-treated 
wood shavings for bedding, and a wire cage top with a food hopper seated 
through a hole in the roof of the cage. The rats were kept under a 12-h reverse 
light cycle, in a temperature controlled environment of (23 ± 1 °C). Food and 
water were available at libitum, except during the period the subjects were being 
tested. Food and water was replenished daily. Where cages were unduly soiled or 
wet they were cleaned and fresh bedding provided, otherwise cages were cleaned 
every 4 days in accordance with the ethical principles of animal husbandry 
stipulated by the University of Waikato. The study received ethical approval from 
the University of Waikato Animal Ethics Committee.  
 
2.2 Study design 
 Ten rats were randomly assigned to one of six groups, three essential oil 
(EO) treated groups, and three control groups. The EO treated groups consisted of 
the bergamot, geranium and combined treatment group. The combined group 
consisted of an equal combination of bergamot and geranium oil. The control 
groups consisted of the odour control, vehicle control and diazepam control 
treatment groups.  
Each group was tested in each of three animal tests of anxiety and 
depression, the elevated plus-maze (EPM), the open-field (OF) and the social 
interaction (SI) test.  
 
2.3 Apparatus 
 The EMP consisted of a black painted wooden maze in the shape of a plus 
sign raised 50cm from the floor. The maze arms where 50x10cm in length with 
closed (protected) arms enclosed with sides 40cm in height with open roof. The 
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open end of the closed arms and similarly the open (unprotected) arms were 
positioned opposite each other extending outward from a central platform 
10x10cm² (Figure 1).  In addition to the normal laboratory lighting, 100W 
anglepoise lamps were utilized to illuminate each open arm. The lamps were 
positioned in such a way as to leave the closed arms in shadow. 
 Open-field activity and social behaviour were tested in a 100x100x600cm 
square Perspex box lined on the outside with black PVC plastic. A 5x5 grid was 
taped to the floor of the open field dividing the arena into 25 squares (20x20cm²), 
effectively creating 3 concentric zones , the central (Zone1), middle (Zone2) and 
outer (Zone3) zones. The outer zone was situated proximal to the wall of the 
open-field (see Figure 2). The floor of the arena was covered with clear PVC for 
ease of cleaning. In addition to the normal laboratory lighting, 100W anglepoise 
lamps were placed on opposite side of the OF, positioned to remove any shadows. 
 Diazepam was given at a dose of 2mg/kg at a volume of 1ml/kg by intra-
peritoneal (i.p.) injection (Pamlin supplied at a concentration of 5mg/ml by 
Newstead Veterinary Practice). Diazepam was diluted to the appropriate 
concentration with sterile water (Water for injection, Baxters, NZ). Vehicle 
controls received an intra-peritoneal (i.p.) injection of sterile water (1ml/kg). The 
injections were given 30mins prior to testing with the rats in a restraint tube. 
 
2.4 Tests procedure 
 Each group of rats were tested on different days to prevent all the rats 
being exposed to the EOs. Each group of rats were placed in the experimental 
room 24 hours before testing began. During this time, rats in the essential oil 
groups were exposed to appropriate odour, whilst the odour, vehicle control and 
diazepam groups were left undisturbed. The essential oils were permeated into the 
air via two electric insect repellent vaporisers placed at opposite ends of the 
testing room, at a dosage of two drops of essential oil per vaporiser every two 
hours.  
Testing was conducted between the hours of 9:00 and 14:00 with the 
laboratory lights on, during the nocturnal phase of the animal’s circadian cycle. 
All the rats were placed in a restraint tube and weighed half an hour prior to 
testing. Rats in the vehicle control and diazepam groups received an i.p. injection 
whilst in the restraint tube and all animals were returned to their home cages prior 
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to testing. The behavioural tests were conducted 48 hours apart in the following 
order: EPM, OF then SI tests. Each group of rats remained in the experimental 
room until all the tests were completed. The 48 hour period between tests 
consisted of 24hr rest period plus a 24hr exposure period for the EO groups; the 
control groups effectively receiving a 48hr rest period. 
 In the EPM trials, the rats were placed on the centre platform 
facing an open arm and allowed to explore for 5 min. Test subject that fell off the 
apparatus were replace in the centre square of the maze facing an open arm.  
In the trials where the open-field was utilized the test subjects were place 
in the centre (Zone1) of the arena facing away from the experimenter and allowed 
to explore for 5 min. A similarly process was conducted for the SI trials, except 
two unfamiliar (non-related) rats, i.e. from two different home cages, were placed 
in the open-field arena simultaneously,  
The apparatus was wiped down with a dilute solution of the cleaning 
detergent used to clean the cages, then dried with paper towel between each trial. 
After each test group had participated in the three sets of trial, the rats were 
returned to their home room and the testing room was cleaned in preparation for 
the next group of rats. The test sessions were recorded with a Panasonic 
Camcorder model PV-GS19 suspended above the testing arena and the rats were 
monitored via a portable television.  
 
2.5 Behavioural measures 
 Spatiotemporal measures in the EPM included the frequency of entries and 
the duration (measured in seconds) of time spent in the open and closed arms and 
centre square of the maze. Percentage measures were calculated as the proportion 
of entries made in relation to the total entries. The scored behaviours included, the 
frequency of head-dips and stretch-attends. Stretch-attend were further 
differentiated as protected or unprotected depending on where they occurred in the 
maze. Protected stretch-attends occurred in the centre square or close arm of the 
maze, unprotected stretch-attends occurring in the open arm of the EPM. 
Anxiolytic response in the EPM would be represented by an increase in frequency 
and time spent in the open arms of the EPM (Pellow, Chopin, File, & Briley, 
1985; Pellow & File, 1986), as well as an increase of risk assessment behaviours, 
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i.e. head-dips and unprotected stretch-attends, in the maze (Rodgers & Dalvi, 
1997). 
 Spatiotemporal measures in the OF included the frequency of entries into 
each zone and the time spent in each of the 3 zones. Behavioural measures 
included the total frequency and duration of immobility, grooming, sniffing and 
rearing. Furthermore the total number of line crossings and the total mobility were 
also measured. Increased locomotion and exploration of the more central zones 
(1&2) of the arena represent an anxiolytic response in the OF (Komori, Fujiwara, 
Tanida, & Nomura, 1995; Vécsei & Widerlöv, 1990). An increase in exploratory 
behaviour, i.e. rears and sniffs and a decrease in immobility and grooming are also 
indicative of an anxiolytic response in the OF (Prut & Belzung, 2003). 
 Behavioural measure in the social interaction test included frequency and 
duration of time apart, in passive contact and in active interactions. All forms of 
bodily contact which did not involve active interaction with test partner were 
defined as passive contact/interaction. Active interaction included sniffing, 
following, fighting and crawling (over or under) test partner. A further measure 
included contact latency, i.e. the length of time it took for the rats to interact from 
the beginning of the trial. Percentage measures were calculated as the proportion 
of behaviour in relation to the total frequency of all the measured behaviours. An 
anxiolytic response in the SI test was as increase in passive and active interaction 
(File & Hyde, 1978; File & Seth, 2003) 
 A program called Hindsight 1.5, a computer assisted behavioural scoring 
program (ScottWeiss, University of Leeds) was used to score the video tapes of 
the rats in each of the tests.  
 
2.6 Statistical analysis 
Statistical analyses were conducted using SPSS for Windows version 11. 
For analysis of the EPM and OF results, odour and vehicle control groups were 
compared by independent group t-test. Similarly, diazepam and the control groups 
were also compared by independent group t-test. One-way between-groups 
ANOVAs were conducted to determine whether there were any significant 
differences in the behaviour measures between the combined control group and 
the EO groups. When ANOVAs were significant post-hoc tests were conducted to 
further investigate the effect. Dunnett’s t-tests were used to compare the treatment 
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groups to the control, whilst Bonferroni corrected t-tests were used to compare 
between the treatment groups when required.  
Considering that individual rat behaviour is influenced by it partner, it is 
suggested that the social behaviours of the rats be measured as a unit rather than 
separately (Genn, Tucci, Marco, Viveros, & File, 2004). The combined 
assessment of test partners effectively reduced the sample size making it 
imperative to utilize non-parametric techniques for analysis SI results; Mann-
Whitney U test was used for pair-wise testing of odour and vehicle control groups, 
and the diazepam and control groups. Kruskal-Wallis tests were conducted to 
determine whether there were any significant differences in the behaviour 
measures between the combined control group and the EO groups. Were an effect 
was found, Mann-Whitney U-tests were used for pair-wise testing of control and 
each of the EO groups, bergamot and combined group, and geranium and the 
combined group to further investigate the effect. Faulty recording made the first 
two test pairs in the odour control difficult to score, consequently they were 
excluded from the analysis. 
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Results 
 
The results are presented in three sections, each addressing one of the 
three novelty evoked models of anxiety utilized in this study. Firstly, within each 
section a comparison will be made between the odour and vehicle control, to 
determine whether they can be pooled. Secondly, the diazepam group will be 
compared to the control group to illustrate the effect of an anxiolytic on rat 
behaviour and establish a baseline for comparison for the anxiolytic properties of 
the essential oils. The EO groups will than be compared to the control to 
determine if they had a significant effect on rat behaviour and whether the 
combining of the oil had a potentiating or additive influence on the anxiolytic 
effectiveness of the oils. Finally, a comparison will be made between the effects 
of the EO groups and the diazepam group 
Sample size constraints prohibited the exclusion of behavioural outliers; to 
this extent all animals were included in the analysis. Further more, it should be 
noted that only significant (p<0.05, p<0.01) and marginally significant (p<0.1) 
results will be presented. 
 
3.1. Elevated-plus Maze 
 Many studies (Dawson & Tricklebank, 1995) have differentiated 
between protected and unprotected risk assessment behaviours, this distinction 
will only be applied to stretch-attend and not head-dip behaviour because it was 
difficult to establish a clear distinction between the protected stretch-attend and 
the protected head-dip behaviours, i.e. all protected risk assessment was 
considered to be stretch-attend behaviour. 
In order to determine whether the control groups could be pooled, an 
independent group t-test was conducted between the odour and vehicle control 
groups. This analysis revealed the vehicle controls made marginally fewer 
[t(18)=1.56, p<0.1] protected stretch-attends than the odour control group. 
Considering there were no other statistically significant variables in any of the 
behaviours measured between the odour and vehicle controls, the controls were 
pooled for any subsequent analyses. These data are summarised in Table 3. 
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Table 3. 
Behaviour of odour and vehicle controls in elevated-plus maze 
 
Behaviour Odour Control  Vehicle Control  
Closed arm  frequency 6.6±1.0 7.0±0.7 
Open arm frequency 1.1±0.5 1.2±0.5 
Centre frequency 8.1±1.1 8.4±0.8 
Closed arm duration 179.6±20.1 187.0±15.9 
Open arm duration 11.3±6.2 25.3±10.7 
Centre duration 109.1±17.6 87.7±9.8 
% Closed arm 42.1±2.7 42.9±2.6 
% Open arm 6.9±2.7 6.5±2.7 
% Centre 51.1±0.5 50.6±0.4 
Head-dip frequency open arm 1.0±0.6 1.5±0.7 
Head-dip duration open arm 3.6±2.4 3.5±1.4 
Unprotected stretch-attend frequency  1.4±0.7 2.1±1.0 
Unprotected stretch-attend duration 6.0±3.1 17.7±8.0 
Protected stretch-attend frequency 6.2±1.1     4.3±0.5$ 
Protected stretch-attend duration 41.6±7.6 30.4±5.1 
Total entries 15.8±2.2 16.6±1.5 
Data are represented as means ± S.E.M. Duration is measured in seconds (s). Sample size – n=10 
odour & vehicle control groups. Level of significance - $= p<0.1 compared to odour control. 
 
 
To determine if 2mg/kg dose of diazepam altered risk assessment 
behaviour on the elevated-plus maze (EPM), an independent group t-test was 
conducted between the pooled control and diazepam groups. These data are 
summarised in Table 4. Compared to the control group, the diazepam group made 
significant more open arm entries [t(28)=2.33, p<0.05] of  marginally longer 
duration [t(28)=1.92, p<0.1], spent marginally more time in the centre 
[t(28)=1.51, p<0.1] and significantly less time in the closed arm [t(28)=2.25, 
p<0.05]  of the EPM. Analysis of the behavioural measures revealed the diazepam 
group made significantly more unprotected stretch-attends [t(28)=1.49, p<0.01], 
as well as significantly more [t(28)=2.33, p<0.5] and longer [t(28)=2.33, p<0.05] 
head-dips than the control group (see Fig 3). Proportionate to the total number of 
entries, the diazepam group made significantly less closed arm entries 
[t(28)=2.39, p<0.5] and more open arm entries [t(28)=2.08, p<0.05]. On the whole 
diazepam increased open arm entries and the time spent in the open arms and 
centre square of the EPM; decreased time spent in closed arms and increased the 
number of head-dips and unprotected stretch-attends. 
 
 44 
Behaviour
Head-dip Unprotected Stretch-attend
Fr
eq
ue
nc
y
0
1
2
3
4
5
6
7 Control 
Diazepam
 
 
 
** 
 
  * 
 
 
Figure 3. Frequency of exploratory behaviour on EPM for control & diazepam groups over a 5 
minute test session. Data are represented as mean ± S.E.M. Level of significance- **p<0.05, 
*p<0.01. 
 
 
One-way between-groups ANOVAs were conducted to determine whether 
there were any significant differences in the behavioural measures between the 
combined/pooled control group and the EO groups. When ANOVAs were 
significant, post-hoc tests were conducted to further investigate the effect. 
Dunnett’s t-tests were used to compare the treatment groups to the control, whilst 
Bonferroni corrected t-tests were used to compare between the treatment groups 
when required.  
Firstly a series of one-way ANOVAs were conducted to investigate the 
behavioural effects of bergamot and a combination of bergamot and geranium 
compared to control rats. The ANOVAs revealed significant differences among 
these groups for closed arm [F(2,37)= 3.48, p<0.05], centre square [F(2,37)= 3.72, 
p<0.05] and total [F(2,37)=3.80, p<0.05] entries; marginally significant 
differences were found for the  number of entries [F(2,37)=2.27, p<0.1] and time 
spent [F(2,37)=2.07, p<0.1] in the open arm, and the frequency [F(2,37)=2.47, 
p<0.1] and duration [F(2,37)=2.12, p<0.1] of unprotected stretch-attends. 
Dunnett’s t-test comparisons of the groups indicate the bergamot group made 
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 Dunnett’s t-test comparisons of the groups indicate the geranium group 
made significantly more closed arm (p<0.01), centre (p<0.01) and total (p<0.01) 
entries than the control group. The combined group made significantly more 
centre square (p<0.05) and total (p<0.05) entries than the control group. On the 
whole, bergamot increased closed arm and centre square entries; geranium 
increased closed arm, centre and total entries; and the combination of bergamot 
and geranium increased the entries into the centre of the maze and the total entries 
made (Fig 4). These data are summarised in Table 4. 
Figure 4. Frequency of exploratory behaviour on EPM for control & essential oil groups over a 5 
minute test session. Data are represented as mean ± S.E.M. Levels of significance - $p<0.01, 
**p<0.05, *p<0.1 compared to control group. 
 
  
Secondly, a series of one-way ANOVAs were conducted to investigate the 
behavioural effects of geranium and a combination of bergamot and geranium 
compared to control rats. The ANOVAs revealed significant differences among 
these groups for closed arm [F(2,37)=6.48, p<0.01], centre [F(2,37)=6.17, p<0.01] 
and total [F(2,37)=6.39, p<0.01] entries, and the frequency of head-dips 
[F(2,37)=2.17, p<0.1].  
significantly more close arm entries (p<0.05) and marginally more centre square 
entries (p<0.1) than the control group.  
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Table 4. 
Behaviour measures of test groups in elevated-plus maze 
 
Behaviour Combined 
Control 
Diazepam 
(2mg/kg) 
Bergamot Geranium Combined 
Closed arm  frequency 6.8±0.6 7.4±1.8    9.0±0.4** 10.0±0.6* 8.1±0.5 
Closed arm duration         183.3±12.5    126.1±26.0**         178.7±11.8§ 187.2±13.4° 170.7±12.4§ 
Open arm frequency 1.2±0.3      2.9±0.8**    0.8±0.2°°   1.1±0.4° 2.2±0.7 
Open arm duration           18.8±6.2    40.7±10.9$    9.7±3.3°°   12.5±5.3°° 33.7±11.1 
Centre frequency 8.3±0.7            10.7±1.9 10.2±0.4$  11.4±0.5*   10.6±0.7** 
Centre duration 98.4±10.1  133.2±25.9$          111.6±11.2           100.4±9.4             95.6±3.7 
% Closed Arm 42.5±1.8     29.0±5.3**   45.0±1.4°°    44.4±1.6°°  39.7±2.6§ 
% Open Arm 6.7±1.9     15.0±4.3**      4.0±1.2°°      5.0±1.7°° 9.4±2.6 
% Centre 50.8±0.3 56.0±4.9 51.0±0.4 50.7±0.4 50.9±0.5 
Head-dip frequency  1.3±0.5    4.1±0.9*     0.9±0.4°    0.7±0.4°  2.8±1.1 
Head-dip duration  3.5±1.3     11.2±3.8**      2.3±1.2°°      1.2±0.7°°  5.4±2.1 
Unprotected stretch-attend frequency  1.8±0.6       4.9±1.1**      1.2±0.4°°       1.6±0.7°°  3.8±1.3 
Unprotected stretch-attend duration 11.8±4.4            15.8±4.5  5.9±1.9    8.5±3.3             22.3±7.0 
Protected stretch-attend frequency   5.3±0.6              4.8±0.9  5.6±0.7    5.1±0.9  6.0±0.6 
Protected stretch-attend duration 36.0±4.6            25.8±6.4 37.4±3.9  26.6±5.6             32.8±3.6 
Total entries 16.2±1.3            21.0±3.8  20.0±0.8    22.5±0.9*     20.9±1.5** 
Data are represented as means ± S.E.M. Duration is measured in seconds (s). Sample size - n=20 control; n=10, diazepam, bergamot, geranium & combined groups. Levels of 
significance - $= p<0.1, **= p<0.05, *= p<0.01 compared to control group; §= p<0.1, °°= p<0.05, °= p<0.01 compared to diazepam.  
Finally, in order to make a comparison between the anxiolytic effects of 
diazepam and the EOs on rat behaviour in the EPM, independent group t-tests 
were conducted. Only the behavioural measures where the diazepam 
demonstrated anxiolytic effects compared to the control rats were included in this 
analysis. Compared to the diazepam group, the bergamot group made significantly 
fewer open arm entries [t(18)=2.44, p<0.05], and spent marginally more time in 
closed arm [t(18)=1.84, p<0.1] and significantly less time in the open arm 
[t(18)=2.72, p<0.05]. The bergamot group also made significantly fewer head-
dips [t(18)=3.28, p<0.01] of shorter duration [t(18)=2.20, p<0.05], and fewer 
unprotected stretch-attends [t(18)=3.07, p<0.05]. Proportionate to the total number 
of entries, the bergamot group made significantly more closed arm entries 
[t(18)=2.90, p<0.05] and significantly fewer open arm entries [t(18)=2.48, 
p<0.05]. Similarly, the geranium group made marginally fewer open arm entries 
[t(18)=1.99, p<0.1], and spent marginally more time in closed arm [t(18)=2.09, 
p<0.1] and significantly less time in the open arm [t(18)=2.33, p<0.05]. The 
geranium group also made significantly fewer head-dips [t(18)=3.42, p<0.01] of 
shorter duration [t(18)=2.54, p<0.05], and fewer unprotected stretch-attends 
[t(18)=2.50, p<0.05]. Proportionate to the total number of entries, the geranium 
group made significantly more closed arm entries [t(18)=2.75, p<0.05] and 
significantly fewer open arm entries [t(18)=2.19, p<0.05]. Independent group t-
test indicates, the only difference between the diazepam and combined group, was 
that the combined group spent marginally more time in the closed arm 
[t(18)=1.55, p<0.1] than the diazepam group, and proportionate to total arm 
entries, the combined group made marginally more closed arm entries 
[t(18)=1.80, p<0.1]. On the whole, bergamot and geranium and the combination 
of the two oils increased the time spent in the closed arm, decreased the number of 
open arm entries and the time spent in the open arms, reduced the frequency and 
duration of head-dips and reduced the frequency of unprotected stretch-attends 
compared to control. Compared to diazepam, the combination of bergamot and 
geranium increased the time spent in the closed arm of the maze.  These data are 
summarised in Table 4.  
 
3.2. Open-field 
  In order to determine whether the control group could be pooled, an 
independent group t-test was conducted between the odour and vehicle control 
groups. This analysis revealed the vehicle controls spent significantly less time in 
Zone1 (centre of arena) [t(18)=2.50, p<0.05] than the odour control group. 
However, considering there were no other statistically significant in any of the 
behaviours measured between the odour and vehicle controls the two groups were 
pooled for any subsequent analyses. These data are summarised in Table 5.  
 
 
Table 5. 
Behaviour of odour and vehicle controls in the open-field test 
Behaviour Odour Control Vehicle Control 
Frequency zone 1 1.5±0.3 1.2±0.2 
Frequency zone 2 3.6±0.9 2.8±0.3 
Frequency zone 3 3.1±0.6 2.6±0.3 
Duration zone 1 6.0±1.1 2.7±0.7* 
Duration zone 2 8.3±2.6 7.8±1.4 
Duration zone 3 285.7±2.5 289.5±1.7 
Total line frequency 44.2±6.5 44.0±4.4 
Total immobile frequency 2.0±0.7 2.5±0.6 
Total immobile duration 12.5±6.8 23.8±10.1 
Total grooming frequency 0.5±0.2 0.6±0.2 
Total grooming duration 5.2±2.4 3.51.3 
Total sniffing frequency 40.7±4.7 38.8±3.8 
Total sniffing duration 171.2±7.5 179.7±11.2 
Total rearing frequency 12.3±2.2 9.8±1.3 
Total rearing duration 13.4±2.5 11.6±1.8 
Total ambulation 97.7±9.9 81.4±9.3 
 
Data are represented as means ± S.E.M. Duration is measured in seconds (s). Sample size - n=10, 
odour & vehicle control. Levels of significance - *= p<0.05 compared to odour control. 
 
 
To determine if 2mg/kg dose of diazepam altered exploratory behaviour in 
the open-field (OF), an independent group t-test was conducted between the 
combined control and diazepam groups. Compared to the control group, the 
diazepam group spent marginally less time in Zone2 (between centre and outer 
zone of arena) [t(18)=1.82, p<0.1] compared to the Control group. Overall the 
diazepam group expressed significantly longer periods of immobility [t(18)=3.38, 
p<0.01], groomed marginally more frequently [t(18)=1.89, p<0.1], sniffed for 
marginally shorter periods [t(18)=1.84, p<0.1], made marginally fewer rears 
[t(18)=1.73, p<0.1] and were marginally less mobile [t(18)=1.87, p<0.1] than the 
control group. On the whole, the analysis illustrates diazepam increased 
 
immobility time, decreased ambulation, increased grooming activity and reduced 
the amount of exploration in the OF (Fig5). These data are summarised in Table 6. 
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Figure 5. Duration of exploratory behaviour in open-field (OF) for control & diazepam groups 
over a 5 minute test session. Data are represented as mean ± S.E.M. Level of significance - $p<0.1, 
*p<0.01. 
 
 
One-way between-groups ANOVAs were conducted to determine whether 
there were any significant differences in the behaviour measures between the 
combined control group and the EO groups. When ANOVAs were significant 
post-hoc tests were conducted to further investigate the effect. Dunnett’s t-tests 
were used to compare the treatment groups to the control, whilst Bonferroni 
corrected t-tests were used to compare between the treatment groups when 
required.  
 Firstly a series of one-way ANOVAs were conducted to investigate the 
behavioural effects of bergamot and the combination of bergamot and geranium 
compared to the control rats. The ANOVAs revealed significant differences 
among these groups for number of entrances into Zone2 [F(2,37)=3,19, p<0.05] 
and Zone3 (outer zone) [F(2,37)=3.92, p<0.05] and marginally significant 
differences in the time spent in Zone1 [F(2,37)=2.14, p<0.1] and Zone2 
[F(2,37)=2.54, p<0.1]. Other significant differences across the test groups include; 
the number of line-crossings [F(2,37)=3.74, p<0.05], and immobile frequency 
 
[F(2,37)=4.94, p<0.05],  with marginally significant differences for the time spent 
immobile [F(2,37)=2.36, p<0.1]. Significant group differences were found for 
time spent sniffing [F(2,37)=3.54, p<0.05], rearing [F(2,37)=5.20, p<0.05], and 
ambulation around the arena [F(2,37)=3.95, p<0.05], with marginally significant 
differences for the number of rears made [F(2,37)=2.61, p<0.1]. Dunnett’s t-tests 
indicated the bergamot group had marginally fewer episodes of immobility 
(p<0.1), spent significantly less time sniffing (p<0.05) and significantly more time 
rearing (p<0.05), and spent significantly more time ambulating/exploring the 
arena (p<0.01) compared to controls. 
 Secondly, a series of one-way ANOVAs were conducted to investigate the 
behavioural effects of geranium and a combination of bergamot and geranium 
compared to control rats. The ANOVAs revealed significant differences among 
the groups for the number of entries into Zone2 [F(2,37)=3.83, p<0.05] and Zone3 
[F(2,37)=6.08, p<0.01] and the amount of time spent in Zone2 [F(2,37)=4.39, 
p<0.05], with marginally significant differences for the amount of time spent in 
Zone3 [F(2,37)=2.44, p<0.1]. Other significant differences across the test groups 
included; the number of line-crossings [F(2,37)=4.24, p<0.05], immobile 
frequency [F(2,37)=6.59, p<0.01], with marginally significant differences in the 
number of  grooming episodes [F(2,37)=2.97, p<0.1]. Marginally significant 
differences were also found for the number of rears made [F(2,37)=2.25, p<0.1], 
with significant differences in the time spent rearing [F(2,37)=4.99, p<0.05]. 
Ambulation time [F(2,37)=2.99, p<0.1] was also significantly different between 
the groups. Dunnett’s t-tests indicated that the geranium group, had significantly 
fewer episodes of immobility (p<0.05) and spent significantly less time immobile 
(p<0.05), had marginally more grooming sessions (p<0.1), and spent marginally 
more time rearing (p<0.1) compared to the control rats.  
When the combined EO group was compared with the control group, 
Dunnett’s t-test indicated that the combined group entered Zone2 (p<0.05) and 
Zone3 (p<0.05) significantly more, and spent significantly more time in Zone2 
(p<0.05). Furthermore, the combined group, made significantly more line 
crossings (p<0.05); experienced significantly fewer episodes of immobility 
(p<0.01) and spent marginally less time immobile (p<0.1), made marginally more 
rears (p<0.1) and spent significantly more time rearing (p<0.01). The combined 
group also spent significantly more time ambulating around the arena (p<0.5). 
 
 Further analysis with Bonferroni post-hoc comparisons revealed the geranium 
group made significantly fewer entries into Zone2 (p<0.05) and Zone3 (p<0.01), 
and spent significantly less time in Zone2 (0.05), and made significantly fewer 
line crossings (p<0.05), and than the Combined group. 
On the whole; bergamot decreased immobility and sniffing and increased 
rearing and overall ambulation/exploration of the open-field; geranium decreased 
immobility and increased grooming and rearing; and the combination of bergamot 
and geranium increase the line crossing, decreased immobility, and increased 
rearing and general ambulation/exploration of the arena (Fig 6).  These data are 
summarised in Table 6. 
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Figure 6. Duration of exploratory behaviour in open-field (OF) for control & diazepam groups 
over a 5 minute test session. Data are represented as mean ± S.E.M. Levels of significance - $= 
p<0.1, **= p<0.05, *= p<0.01 compared to control group; aa= p<0.05 compared to combined 
group; ₤p<0.1; °°= p<0.05, °= p<0.01 compared to diazepam. 
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Table 6. 
Behaviour of test groups in the open-field 
Behaviour Combined 
Control 
Diazepam 
(2mg/kg) 
Bergamot Geranium Combined 
Frequency zone 1 1.4±0.2 1.5±0.3 1.3±0.2 1.5±0.2 1.8±0.4 
Frequency zone 2 3.2±0.5 3.1±0.8 3.3±0.4 2.6±0.6ªª 5.2±0.9** 
Frequency zone 3 2.9±0.3 2.8±0.7 3.0±0.4 2.0±0.4ª 4.6±0.7** 
Duration zone 1 4.4±0.8 10.3±6.2 2.2±0.3 3.9±1.0 3.0±0.8 
Duration zone 2 8.0±1.5 4.0±1.1$ 11.0±2.5°° 5.8±1.6ªª 14.9±3.2**° 
Duration zone 3 287.6±1.5 285.7±6.0 286.8±2.7 290.3±2.4 282.1±3.8 
Total line frequency 44.1±3.8 51.9±6.8 50.2±2.6 42.3±3.6ªª 58.6±3.1** 
Total immobile frequency 2.3±0.5 2.5±0.6 0.9±0.5$ 0.6±0.3** 0.3±0.2* 
Total immobile duration 18.2±6.1 62.0±13.9* 10.1±4.7° 15.8±9.3**°° 0.8±0.4$° 
Total grooming frequency 0.6±0.2 1.1±0.3$ 1.1±0.3 1.4±0.3$ 0.9±0.3 
Total grooming duration 4.4±1.4 6.9±2.0 7.0±2.5 6.8±1.7 7.5±2.8 
Total sniffing frequency 39.8±3.0 35.3±4.1 38.4±2.8 38.5±2.6 45.9±2.3 
Total sniffing duration 175.4±6.7 154.5±8.9$ 150.8±5.2** 169.0±6.2 156.1±8.6 
Total rearing frequency 11.1±1.3 7.0±2.1$ 15.5±2.4°° 13.7±2.0°° 15.7±1.8$° 
Total rearing duration 12.5±1.5 8.8±3.1 21.3±3.8** 18.4±2.8$ 21.3±2.5* 
Total ambulation 89.5±6.9 67.7±9.2$ 110.8±4.6*° 90.0±7.3₤ 114.2±7.7**° 
 
Data are represented as means ± S.E.M. Duration is measured in seconds (s). Sample size - n=20 control; n=10, diazepam, bergamot, geranium & combined groups. Levels of 
significance - $= p<0.1, **= p<0.05, *= p<0.01 compared to control group; aa= p<0.05, a= p<0.01, compared to combined group; ₤p<0.1; °°= p<0.05, °= p<0.01 compared to 
diazepam. 
Finally, in order to make a comparison between the anxiolytic effects of 
diazepam and the EOs on rat behaviour in the OF, independent group t-tests were 
conducted. Only the behavioural measures where the diazepam demonstrated 
significant differences compared to the control rats were included in this analysis. 
Compared to the diazepam group, the bergamot group spent significantly more 
time in Zone2 [t(18)= 2.49, p<0.05], spent significantly less time immobile 
[t(18)=3.55, p<0.01], made significantly more rears [t(18)=2.66, p<0.05] and 
spent significantly more time ambulation/exploring the arena [t(18)=4.19, 
p<0.01]. Similarly, the geranium group spent significantly less time immobile 
[t(18)=2.77, p<0.05], made significantly more rears [t(18)=2.36, p<0.05] and 
spent marginally more time ambulation/exploring the open-field [t(18)=1.90, 
p<0.1]. T-tests between the diazepam and combined group indicate, the combined 
group spent significantly more time [t(18)=3.20, p<0.01] in Zone2, was immobile 
for a significantly shorter period of time [t(18)=3.45, p<0.01], made significantly 
more rears [t(18)=3.19, p<0.01], and spent significantly more time 
ambulating/exploring the open-field [t(18)=3.88, p<0.01]. On the whole it appears 
bergamot and the combination of bergamot and geranium increased the time spent 
in Zone2, and both the single oil and the combined oil group reduced immobility, 
increased rearing and increased the overall ambulation/ exploration of the test 
arena compared to diazepam. These data are summarised in Table 6.  
3.3. Social Interaction 
All analyses for the SI test were carried out using non parametric statistics 
as the pairs of animals were scored as a unit resulting in an n of five per group. 
Mann-Whitney U tests were used for pair-wise comparison of odour and vehicle 
control groups to determine whether the control groups could be pooled. These 
analyses revealed the vehicle control spent significantly longer crawling over or 
under test partner than the odour control group [U= -2.24, p<0.05]. Considering 
there were no other statistically significant variables in any of the behaviours 
measured between the odour and vehicle controls, the two groups were pooled for 
any subsequent analyses. These data are summarised in Table 7.  
 
Table 7. 
Social interactive behaviour of odour and vehicle control groups in open-field 
Behaviour Odour Control Vehicle Control 
Contact latency (8.5)9.9(16.6) (5.7)9.9(28.9) 
Separation frequency (16.0)17.0(24.0) (14.5)17.0(19.0) 
Passive interaction frequency (9.0)14.0(26.0) (7.0)12.0(14.5) 
Sniffing frequency (21.0)22.0(29.0) (20.0)21.0(26.0) 
Following frequency (4.0)7.0(21.0) (6.0)9.0(10.5) 
Crawl frequency (1.0)2.0(2.0) (2.0)2.0(2.0) 
Fight frequency (0.0)0.0(0.0) (0.0)0.0(0.0) 
Separation duration (128.9)211.8(219.4) (179.7)201.5(204.1) 
Passive interaction duration (13.9)30.8(50.9) (16.8)23.5(29.9) 
Sniffing duration (28.2)37.9(38.2) (46.8)57.3(69.5) 
Following duration (6.9)12.7(20.4) (15.2)19.5(26.0) 
Crawl duration (1.7)1.9(3.6) (2.7)3.6**(6.6) 
Fight duration (0.0)0.0(0.0) (0.0)0.0(0.0) 
% Separation (23.3)29.1(29.3) (24.5)27.4(30.0) 
% Passive interaction (16.4)24.1(25.2) (10.9)19.4(25.0) 
% Sniffing (28.2)37.9(38.2) (33.0)36.8(40.3) 
% Following (6.9)12.7(20.4) (10.4)14.8(16.2) 
% Crawling (1.7)1.9(3.6) (3.1)3.4(5.9) 
% Fighting (0.0)0.0(1.0) (0.0)0.0(0.0) 
% Active interaction (46.6)51.5(54.5) (48.4)53.2(61.2) 
Data are represented as (25th percentile) median (75th percentile). Duration is measured in seconds 
(s). Sample size - n=3 odour control, n=5 for vehicle control. Levels of significance – two tailed 
Mann-Whitney U-test, **= p<0.05 compared to odour control. 
 
To determine if the 2mg/kg dose of diazepam altered behaviour in the 
open-field (OF), Mann-Whitney U tests were used for pair-wise comparisons 
between the pooled control and diazepam groups. Compared to the control group, 
the diazepam group made significantly fewer sniffs [U=-2.94, p<0.01], followed 
[U=-2.50, p<0.05], crawled [U=-2.30, p<0.05] separated [U=-2.66, p<0.01] and 
made passive contact [U=-1.92, p<0.05] with partner significantly less often then 
the control group. Proportionate to the total frequency of behaviours measured, 
the diazepam group separated marginally more often [U=-1.76, p<0.1], and made 
 
significantly fewer active interactions [U=-2.34, p<0.05] with test partner than the 
control group. On the whole, the analysis illustrates diazepam decreased the 
frequency of separations, sniffs, follows, crawls, passive and active interactions 
with test partner (Fig 7). These data are summarised in Table 8. 
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Figure 7. Social interactive behaviours of rats in control and diazepam groups in open-field (OF). 
Rats were placed in centre of arena and left to interact for 5 minutes. Data are represented as mean 
percentage of frequency ± S.E.M. Level of significance - $p<0.1, *p<0.01. 
 
Kruskal-Wallis tests were conducted to determine whether there were any 
significant differences in the behavioural measures between the combined/pooled 
Control group and the Essential Oil groups. Where an effect was found (p<0.1), 
two-tailed Mann-Whitney U-tests were used for pair-wise comparisons. 
 Firstly, a series of Kruskal-Wallis tests were conducted to investigate the 
behavioural effects of bergamot and the combination of bergamot and geranium 
compared to the control rats. The Kruskal-Wallis tests revealed significant 
differences among these groups for; contact latency [W(2, N=18)=6.28, 
p<0.05],the number of separations [W(2, N=18)=4.28, p<0.1], sniffs [W(2, 
N=18)=8.95, p<0.05], follows [W(2, N=18)=3.94, p<0.1], and time spent apart 
[W(2, N=18)=8.87, p<0.5] and sniffing duration [W(2, N=18)=9.41, p<0.01].  
Secondly, a series of Kruskal-Wallis tests were conducted to investigate 
the behavioural effects of geranium and a combination of bergamot and geranium 
 
 Figure 8. Frequency of social interaction of rats in OF for control & essential oil groups over a 5 
minute test session. Data are represented as mean ± S.E.M. Level of significance- $p<0.1, 
**p<0.05, *p<0.01. 
Further analysis with Mann-Whitney U-tests revealed, bergamot group 
experienced a significantly shorter contact latency [U=-2.05, p<0.05], made 
marginally more sniffs [U=-1.70, p<0.1] and follows [U=-1.54, p<0.1]; and spent 
significantly less time sniffing [U=-2.34, p<0.05] and apart [U=-2.05, p<0.05] 
from test partner compared to the control group. The geranium group, spent 
significantly less time apart [U=-2.34, p<0.05] and sniffing [U=-2.20, p<0.05] test 
partner than the control group. Further more, Mann-Whitney U-tests revealed, the 
combined group experienced a significantly shorter contact latency [U=-2.05, 
p<0.05], made significantly more separations [U=-2.21, p<0.05] and sniffs [U=-
2.69, p<0.01], and followed partner marginally more often [U=-1.32, p<0.1] than 
the control group. The combined group also spent significantly less time apart 
[U=-2.64, p<0.01] and sniffed partner for significantly longer [U=-2.64, p<0.01] 
than the control group.  
compared to control rats. The Kruskal-Wallis tests revealed significant differences 
among these groups for; contact latency [W(2, N=18)=4.96, p<0.1], the number of 
sniffs [W(2, N=18)=5.19, p<0.1], and the time spent apart [W(2, N=18)=9.55, 
p<0.01] and sniffing duration [W(2, N=18)=9.10, p<0.05]. 
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Table 8. 
Social interactive behaviour of test groups in open-field 
Behaviour Pooled Control Diazepam (2mg/kg) Bergamot Geranium Combined 
Contact latency (7.9)9.9(16.2) (6.5)8.5(81.6) (2.9)3.6**(7.5) (5.8)13.8₤(35.4) (2.1)2.5**(9.6) 
Separation frequency (16.0)17.0(19.5) (7.5)8.0*(12.5) (16.0)23.0°°(25.5) (11.5)19.0°°(28.0) (20.0)21.0**°(25.0) 
Passive interaction frequency (7.5)13.0(14.8) (4.0)7.0**(10.5) (8.0)12.0₤(24.5) (11.0)15.0°°(15.0) (14.0)15.0°°°(24.5) 
Sniffing frequency (21.0)21.5(27.0) (5.5)10.0*(14.0) (24.0)32.0$§°(36.5) (19.0)28.0°(45.5) (32.5)38.0*°(38.0) 
Following frequency (5.5)8.0(10.8) (0.5)2.0**(5.0) (9.0)12.0°(16.0) (8.0)15.0°°(18.5) (9.0)12.0$°(21.0) 
Crawl frequency (2.0)2.0(2.0) (1.0)1.0**(1.5) (1.0)2.0(3.5) (0.5)2.0(3.5) (0.0)2.0(5.0) 
Fight frequency (0.0)0.0(0.0) (0.0)0.0(0.0) (0.0)0.0(0.5) (0.0)0.0(0.0) (0.0)0.0(1.0) 
Separation duration (175.6)201.6(210.5) (194.9)211.6(220.7) (116.7)129.2**(183.1) (121.7)154.2**(163.6) (98.5)115.2*(148.3) 
Passive interaction duration (16.0)24.3(33.7) (15.6)24.8(47.2) (19.8)29.3(56.3) (20.6)24.4(59.5) (28.8)47.4(54.1) 
Sniffing duration (47.6)55.2(65.1) (37.2)48.8(54.2) (64.5)75.9**(105.1) (63.2)86.5**(109.1) (77.4)94.7*(128.8) 
Following duration (14.4)18.0(26.3) (1.5)6.5(27.2) (15.6)27.2(42.3) (22.8)31.0(36.3) (16.5)19.5(41.5) 
Crawl duration (1.5)2.7(3.7) (0.9)1.0(4.2) (1.8)2.9(4.9) (0.6)2.0(3.5) (0.0)3.3(11.6) 
Fight duration (0.0)0.0(0.0) (0.0)0.0(0.0) (0.0)0.0(7.6) (0.0)0.0(0.0) (0.0)0.0(4.6) 
% Separation (24.0)28.3(29.4) (26.7)32.4$(39.6) (24.1)26.0°(27.6) (20.9)24.7°(26.9) (19.2)22.8°(31.1) 
% Passive interaction (12.7)21.7(25.1) (17.1)25.0(27.6) (11.4)15.8(25.7) (13.7)18.2(22.5) (15.7)20.0(23.0) 
% Sniffing (32.6)37.4(39.1) (26.3)30.8(37.2) (35.5)36.8(39.4) (36.3)38.2(41.2) (35.7)38.6(41.1) 
% Following (9.4)13.7(16.2) (1.8)6.5(15.1) (10.4)18.2(19.3) (12.8)18.8(19.7) (11.1)13.4(19.7) 
% Crawling (2.2)3.3(3.6) (2.6)3.6(7.1) (1.1)2.2(5.1) (1.1)3.0(3.5) (0.0)1.9(5.2) 
% Fighting (0.0)0.0(0.0) (0.0)0.0(0.0) (0.0)0.0(0.9) (0.0)0.0(0.0) (0.0)0.0(1.1) 
% Active interaction (47.8)52.9(58.9) (41.0)44.4**(47.3) (47.4)60.0°°(62.9) (52.4)59.2°°(62.6) (51.9)55.6°(61.0) 
 
Data are represented as (25th percentile)median(75th percentile). Duration is measured in seconds (s). Sample size - n=5 for diazepam, bergamot, geranium & combined 
groups, n=8 pooled control. Levels of significance – two tailed Mann-Whitney U-test, $= p<0.1, **= p<0.05, *= p<0.01 compared control, §= p<0.1 compared to combined 
group, ₤= p<0.1, °°= p<0.05, °= p<0.01 compared to diazepam.  
Mann-Whitney U-tests between the EO groups revealed, the bergamot 
group made marginally fewer sniffs [U=-1.83, p<0.1], and the contact latency 
between test partners of the geranium group was marginally longer [U=-1.78, 
p<0.1] than the combined group. On the whole; bergamot decreased contact 
latency, increase sniffing and following and decreased separation, geranium 
increased sniffing and decreased separation, and the combination of bergamot and 
geranium decreased contact latency and separation, and increased sniffing and 
following of test partners (Fig 8). These data are summarised in Table 8. 
Discussion 
 
The overall aim of the thesis was to evaluate the effects of bergamot and 
geranium essential oils in three different tests of anxiety. The anxiolytic diazepam 
was used as a positive control. 
Diazepam increased the time spent in and the number of entries to the 
open arm of the EPM, along with increased risk assessment behaviour. In the OF 
diazepam produced an increase in immobility time, and a reduction in ambulation 
and time spent in Zone2. Exploratory behaviour was also decreased by diazepam, 
with rats making fewer rears and spending less time sniffing the arena. In addition 
grooming frequency was increased by diazepam. In the SI test, diazepam 
decreased passive and active interactions between rat pairs. Behaviourally, 
diazepam caused a decrease in sniffing and following of partner as well as 
decrease in the frequency of separations in the SI test. The increase exploration 
and risk assessment in the open arms is indicative of an anxiolytic effect of 
diazepam on rats in the EPM. The decrease in locomotion and exploration in the 
OF might be indicative of a sedating effect of diazepam on rat behaviour. 
However when take in context to the increased grooming behaviour and 
immobility, the decreases in locomotion and exploration indicates diazepam had 
an anxiogenic effect. The decreased frequency of separation together with the 
decrease in active interaction between test partners would suggest diazepam had a 
sedating effect on rat behaviour. However if one considers the decreased 
separation frequency is relative to the decreases in passive interaction, diazepam 
had an anxiogenic effect on social interactive behaviours.   
A 24 hour exposure to bergamot odour produced an increase in close arm, 
centre square and the total number of entries made in the EPM. Following 
exposure to bergamot, rats showed fewer episodes of immobility, increased the 
time spent sniffing and rearing, and the time ambulating/exploring the OF. In the 
SI test, rats exposed to the odour of bergamot for 24 hours produced shorter 
contact latency, decreased the time spent sniffing partner, but increased the 
frequency of sniffing and follows between test partners. Furthermore, bergamot 
decreased the time test partners spent apart. The increase in total entries suggests 
that bergamot had a simulating effect in the EPM. The increase in locomotion and 
 
exploratory behaviour suggests bergamot had and anxiolytic effect in OF. In the 
SI test, the shorter contact latency and increased passive and active interaction 
between the rats is indicative of the anxiolytic effect of bergamot. 
A similar exposure to the odour of geranium produced an increase in close 
arm, centre square and total entries in the EPM. Geranium produced a decrease in 
the frequency and duration of immobility, increased the frequency of grooming 
and increased the time spent rearing in the OF. In the SI test, geranium caused a 
decrease in the time test partners spent apart and an increase in the time spent 
sniffing partner. The increase in total entries also indicates the simulating effect of 
geranium in the EPM. The increase of grooming frequency could indicate that 
geranium had an anxiogenic effect in the OF. However, when compared to a 
decrease in immobility and the increase in time spent rearing, it appears that 
geranium had an anxiolytic effect in the OF. In the SI test, the decrease in time the 
rats spent apart from partner and the increase in active interaction, i.e. partner 
sniffing suggests geranium had an anxiolytic effect. 
Exposure to combination of bergamot and geranium produced an increase 
in centre square and total entries in the EPM. The oil combination increase the 
number of entries into Zone2 and Zone3 and the time spent in Zone2 in the OF. 
Furthermore, the combination produced an in decrease in immobility frequency 
and duration and an increase in the frequency and duration of rears. The 
combination of bergamot and geranium also produced an increase in the 
frequency of line crossing and the time spent ambulating around the arena. In the 
SI test the essential oil combination produced shorter contact latency between test 
partners. Furthermore, the frequency of sniffing and following of partner was 
increased by the combination of oils. The duration of time spent following partner 
was also increased.  In addition, test partners separated more often but the time 
spent apart was decreased by the combination of bergamot and geranium. In the 
EPM the bergamot and geranium combination had a stimulating effect as 
demonstrated by an increase in total entries. The increased locomotion and 
exploration of Zone2 as well as the increase in frequency and duration of rears 
suggests the combination of EOs had an anxiolytic effect in the OF. In the SI test, 
shorter contact latency between test partners coupled with an increase in active 
and passive interaction indicates the anxiolytic effect of the combination of 
bergamot and geranium.  
 
With regards to diazepam, the results of this study are consisted with other 
research which indicate diazepam can have an anxiogenic effect on rat behaviour 
in the OF and SI tests (Prut & Belzung, 2003). What is surprising however is 
considering the analogous nature of the EPM, OF and SI models; one would have 
expected diazepam to have had a similar effect in all three tests. A plausible 
explanation for the differing results could be that the different models of anxiety 
are taping into different levels or types of anxiety, i.e. stress, fear or worry.  It also 
suggests that when studying anxiolytics you need to look at their effects in more 
that one test.  
In contrast to the present study, previous studies reported the essential oils, 
lemon verbena (Vale, Matos, de Lima, & Viana, 1999), woundwort (Rabbani, 
Sajjadi, & Zarei, 2003) and bitter orange (Carvalho-Freitas & Costa, 2002) 
demonstrated an anxiolytic effect on mice in the EPM by increasing the amount of 
entries and time spent in the open arms. These differences are hardly surprising 
considering different oils and species are being compared. More importantly 
however, is the fact the present study used inhalation as the mode of essential oil 
administration, not ingestion (oral) or the intra-peritoneal (injection) mode as was 
used in these studies. The inhalation of lavender has also demonstrated anxiolytic 
effect on gerbils in the EPM by increasing risk assessment behaviour (Bradley, 
Starkey, Brown, & Lea, 2007) but once again species and oil variation could 
account for this difference.  On the other hand, the effects of EOs in the OF and SI 
in this study are supported by previous research, which report EOs demonstrate 
anxiolytic properties in the OF (Ambavade, Mhetre, Tate, & Bodhankar, 2006) 
and SI tests (Leite et al., 2008) by increasing locomotion and exploration, active 
and passive interaction, respectively. 
Like diazepam, there appears to be a conflict between the effect of the EOs 
observed in the EPM and the effects of the EOs in the OF and SI tests. Research 
suggest that poor correlations (Tonissaar, Philips, Eller, & Harro, 2004) and 
inconsistent drug effects (Green, 1991) across different animal models of anxiety 
and depression  indicates that there are other mechanisms at work than just 
generalised anxiety, i.e. different animal models could be taping different aspect 
of anxiety. One explanation for these behavioural inconsistencies could be the 
difference between trait (a motive or acquired behavioural disposition that 
predisposes an individual to perceive a wide range of objectively non-dangerous 
 
circumstances as threatening) and state anxiety (characterized by subjective, 
consciously perceived feelings of apprehension and tension, accompanied by or 
associated with activation or arousal of the autonomic nervous system) (Spielberg, 
as cited in Wrisberg, 1994). It has been suggested that lack of test/re-test stability 
illustrates that the elevated plus-maze is a better measure of state anxiety because 
novel exploration of the open arms is not stable but reduces with successive 
testing (Andreatini & Bacellar, 2000). Contrastingly, it has been suggested the 
open-field test is a better test of trait anxiety because of the lack of consistency 
between effect of different benzodiazepines (Prut & Belzung, 2003). As discussed 
earlier, effect variation across different models of animal anxiety is justified if one 
assumes the different tests are measuring different forms of anxiety. However, an 
alternative explanation could be that the EOs are operating via a different pathway 
to diazepam, i.e. not via GABA receptors, because they share similar behavioural 
profiles to SSRIs or amphetamines in the EPM (Prut & Belzung, 2003). As such it 
might be more appropriate to assess the anxiolytic effectiveness of EOs in 
comparison to SSRI or amphetamines rather than benzodiazepines.  
A plethora of research has focused on single essential oils or their 
individual component (Sakamoto, Minoura, Usui, Ishizuka, & Kanba, 2005; Torii, 
1997), few have examined the potentiating or additive effects of the combined 
components on the effectiveness of the individual essential oils which is a 
common practice amongst aromatherapists (Atanassova-Shopova & Roussinov, 
1970; Komori et al., 2006; Lemon, 2004). The present study demonstrates the 
addition of bergamot had a potentiating effect on the anxiolytic properties of 
geranium in the OF because it caused an increase in the number of entries into 
Zone2 and Zone3, and the number of line crossings. Furthermore the addition of 
bergamot to geranium increased the time spent in Zone2.  The combination of 
EOs also had an additive influence on the anxiolytic properties of bergamot in the 
SI test by increasing active interactive behaviours, i.e. the sniffing and following 
of test partners. Similarly, the combination of EOs had potentiating effect on 
geranium because the contact latency between the test partners was decreased. As 
such, this study indicates that further research is necessary to determine the 
importance of the unique composition of EOs on their overall effectiveness, and 
whether the potentiating effect of the combined oils observed in this study 
 
transcends to different combinations and if there is an optimal number of oils that 
may be combined at any one time.  
In this study the different effects of diazepam and the EOs, in the EPM, 
OF and SI tests clearly highlight the need for further research to determine 
whether the animal models of anxiety are indeed testing the same level/type of 
anxiety. Although diazepam is considered the gold standard for the evaluation of 
anxiolytic effects in animal models of anxiety and depression, differences 
between the effect of diazepam and the EOs in this study suggest further research 
is needed to determine if the anxiolytic profiles of EOs are best compared to 
SSRIs or amphetamines rather than diazepam. As outlined earlier, lack of 
conformity in the research methodologies has produced conflicting conclusions as 
to the anxiolytic and anti-depressant properties of EOs. Considering the normal 
method of EO administration in humans is via absorption through the skin or 
inhalation, it would seem that studies utilizing i.p. or oral methods of 
administration are inappropriate. Furthermore, in some studies animals have been 
placed in an enclosed chamber or restraint tube where the flow or volume of EO 
the animals are exposed to is precisely controlled (Shaw, Annett, Doherty, & 
Leslle, 2007). However, considering the delivery of EO in humans is either 
through a vaporiser or steam/oil bath this form of delivery should also be 
considered inappropriate when studying the effect of EO. It is therefore suggested 
that these points be taken into consideration when conducting further research into 
the effects of EOs on human or animal behaviour.  
Research also indicates the psychological and physiological effectiveness 
of EOs may be dose dependant (Umezu, 2000). Animal studies have indicated the 
length of exposure to odorised EOs impacts on effectiveness of the oil to 
influence behaviour;  stimulating essential oils appear more dose dependant than 
sedating oils (Shaw, Annett, Doherty, & Leslle, 2007). These findings are 
supported by MRI studies which illustrate that prolonged exposure to an odour 
results in the habituation of the olfactory receptors and the olfactory cortex 
(Poellinger et al., 2001). In this study the test animals were exposed to 4 drops of 
EO every 2 hours over a 24 hour period. Research has examined effects of acute 
and chronic exposure to EOs (Bradley, Starkey, Brown, & Lea, 2007), however 
no consensus has been established as to the optimal dose of EO per room size or 
an optimal exposure time or regime. Further research should also be conducted to 
 
determine the effect of an intermittent period of exposure, i.e. a period of 
exposure that is broken intermitted by periods of non-exposure, because this 
schedule of exposure more accurately mirrors the process of exposure in the 
natural environment.  
Test conditions may also alter rat’s behaviour in many tests of anxiety. For 
example, File and Seth (2003) attest that high illumination of a novel arena (open-
field) is sufficient to generate high levels of anxiety in rats. Consequently, rats 
display less social interaction under high illumination conditions (File &Seth, 
1978). High illumination is also demonstrated to increase anxiety related 
behaviours in the elevated plus maze (Griebel, Moreau, Jenck, Martin, & Misslin, 
1993; Hale, Bouwknecht, Spiga, Shekhar, & Lowry, 2006). There seems to be no 
consistency as to whether animals should be tested during the light or dark phase 
of their circadian cycle. Rats are nocturnal and therefore more active at night, it is 
possible that the lack of responsiveness to EOs reported in research could be 
attributed a natural reduction of activity during the light phase of rats circadian 
cycle. Further studies could identify whether the time of testing impacts on the 
behavioural responses of rats exposed to EOs. Many animal models rely on the 
anxiety generated by high levels of illumination; it would be interesting to see if 
the same level of lighting generate the same level of anxiety when the animal are 
test during the light or dark phase of their circadian cycle.  
 
4.1. Limitations  
As pointed out by Calatayud, Belzung and Aubert (2004), inter-individual 
testing variability could also be an influencing factor to lack of consensus as to the 
effect EOs. In this study, prolonged care may have resulted in the rats habituating 
to handling could have influenced their behaviour in the tests, i.e. the levels of 
anxiety observed in the EPM, OF and SI tests. Arakawa (2007) proposes that risk 
assessment behaviour emerges in juvenile rats (around 40 days),   peak during 
adolescent stage of development (65 days) and drops off as rats reach maturity 
(130 days) and remains stable throughout adulthood.  
In this study sample size was limited to 10 rats per test group. In the SI test 
the combined assessment of test partners effectively halved the sample size. 
Research has demonstrated that larger samples show greater stability and power, 
smaller standard deviations and provide a more accurate projection about 
 
population trends (MacCallum & Widaman, 1999). Consequently, as pointed out 
by Moher, Dulberg and Wells (1994), if a trial with negative results has 
insufficient power; a clinically important but statistically non-significant effect is 
usually ignored or taken to mean the treatment made of difference. With this in 
mind a larger sample per group would have provided more power to the study and 
produce a more robust indication of the anxiolytic effect of EOs in the tests of 
anxiety.  
 
4.2. Conclusion 
Considering the prevalence and debilitating effects anxiety and depression 
have on ones ability to function, it not surprising that that drugs like diazepam are 
prescribed because of the swiftness and efficacy with which they operate.   Sadly 
psychotropic drugs are associated with serious negative side effects and the risk of 
addiction. For this reason, pharmaceuticals like diazepam are only recommended 
for short term use. With this in mind it would seem appropriate to find a treatment 
solution for anxiety and depression that can be used more extensively without the 
associated contraindicative risk to health.  
Essential oils have been offered as a plausible alternative to conventional 
treatment approaches for anxiety and depression; however there is insufficient 
empirical evidence to support their efficacy. Unfortunately, most of the essential 
oil studies have relied on animal research to investigate the effects EOs may have 
on human behaviour, which is hardly surprising considering the hedonic valence 
associated with aromas.  However, there is little consensus about the appropriate 
testing methods and which of the myriad of psychotropic drug associated with the 
treatment of anxiety or depression are more appropriate as a positive control. 
Furthermore, many of the more familiar essential oils have been investigated 
however they are not necessarily the most appropriate oils for the treatment of 
human depression and or anxiety.  In addition, research has focused on the effects 
of single oils rather than the combination of several oils which is generally the 
practice in aromatherapy. 
The present study established that bergamot and geranium, essential oils 
more commonly used for the treatment of anxiety and depression in aromatherapy 
had a positive anxiolytic effect on rat behaviour when inhaled. Furthermore the 
 
study also demonstrated that the combining of the oils had a potentiating effect on 
the anxiolytic properties of the single oils.  
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